<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Adjuvant chemotherapy for advanced endometrial cancer - Galaal, K - 2014 | Cochrane Library</title> <meta content="Adjuvant chemotherapy for advanced endometrial cancer - Galaal, K - 2014 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010681.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Adjuvant chemotherapy for advanced endometrial cancer - Galaal, K - 2014 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010681.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010681.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Adjuvant chemotherapy for advanced endometrial cancer" name="citation_title"/> <meta content="Khadra Galaal" name="citation_author"/> <meta content="Princess Alexandra Wing, Royal Cornwall Hospital" name="citation_author_institution"/> <meta content="k.galaal@nhs.net" name="citation_author_email"/> <meta content="Mansour Al Moundhri" name="citation_author"/> <meta content="College of Medicine and Health Sciences and Sultan Qaboos University Hospital" name="citation_author_institution"/> <meta content="Andrew Bryant" name="citation_author"/> <meta content="Newcastle University" name="citation_author_institution"/> <meta content="Alberto D Lopes" name="citation_author"/> <meta content="University of Exeter Medical School" name="citation_author_institution"/> <meta content="Theresa A Lawrie" name="citation_author"/> <meta content="The Evidence-Based Medicine Consultancy Ltd" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="5" name="citation_issue"/> <meta content="10.1002/14651858.CD010681.pub2" name="citation_doi"/> <meta content="2014" name="citation_date"/> <meta content="2014/05/15" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010681.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010681.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010681.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Antineoplastic Combined Chemotherapy Protocols [*therapeutic use]; Chemoradiotherapy; Chemotherapy, Adjuvant [adverse effects, methods, mortality]; Cisplatin [administration &amp; dosage]; Disease-Free Survival; Doxorubicin [administration &amp; dosage]; Endometrial Neoplasms [*drug therapy, mortality, pathology, therapy]; Neoplasm Staging; Paclitaxel [administration &amp; dosage]; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010681.pub2&amp;doi=10.1002/14651858.CD010681.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010681.pub2&amp;doi=10.1002/14651858.CD010681.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010681.pub2&amp;doi=10.1002/14651858.CD010681.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010681.pub2&amp;doi=10.1002/14651858.CD010681.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010681.pub2&amp;doi=10.1002/14651858.CD010681.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010681.pub2&amp;doi=10.1002/14651858.CD010681.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010681.pub2&amp;doi=10.1002/14651858.CD010681.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010681.pub2&amp;doi=10.1002/14651858.CD010681.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010681.pub2&amp;doi=10.1002/14651858.CD010681.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010681.pub2&amp;doi=10.1002/14651858.CD010681.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010681.pub2&amp;doi=10.1002/14651858.CD010681.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010681.pub2&amp;doi=10.1002/14651858.CD010681.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010681.pub2&amp;doi=10.1002/14651858.CD010681.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010681.pub2&amp;doi=10.1002/14651858.CD010681.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010681.pub2&amp;doi=10.1002/14651858.CD010681.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010681.pub2&amp;doi=10.1002/14651858.CD010681.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010681.pub2&amp;doi=10.1002/14651858.CD010681.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010681.pub2&amp;doi=10.1002/14651858.CD010681.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010681.pub2&amp;doi=10.1002/14651858.CD010681.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010681.pub2&amp;doi=10.1002/14651858.CD010681.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010681.pub2&amp;doi=10.1002/14651858.CD010681.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010681.pub2&amp;doi=10.1002/14651858.CD010681.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010681.pub2&amp;doi=10.1002/14651858.CD010681.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="Nio3SV1W";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010681\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010681\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010681\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010681\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","zh_HANT","hr","fa","ms"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010681.pub2",title:"Adjuvant chemotherapy for advanced endometrial cancer",firstPublishedDate:"May 15, 2014 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Nio3SV1W&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010681.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010681.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010681.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010681.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010681.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010681.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010681.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010681.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010681.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010681.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>4072 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010681.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010681.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010681.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010681.pub2/full#CD010681-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010681.pub2/full#CD010681-sec-0056"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010681.pub2/full#CD010681-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010681.pub2/full#CD010681-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010681.pub2/full#CD010681-sec-0013"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010681.pub2/full#CD010681-sec-0014"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010681.pub2/full#CD010681-sec-0036"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010681.pub2/full#CD010681-sec-0050"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010681.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010681.pub2/appendices#CD010681-sec-0061"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010681.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010681.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/table_n/CD010681StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/table_n/CD010681StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010681.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010681.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010681.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010681.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010681.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010681.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2014 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Adjuvant chemotherapy for advanced endometrial cancer</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010681.pub2/information#CD010681-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Khadra Galaal</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010681.pub2/information#CD010681-cr-0005">Mansour Al Moundhri</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010681.pub2/information#CD010681-cr-0006">Andrew Bryant</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010681.pub2/information#CD010681-cr-0007">Alberto D Lopes</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010681.pub2/information#CD010681-cr-0008">Theresa A Lawrie</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/information/en#CD010681-sec-0068">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 15 May 2014 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010681.pub2">https://doi.org/10.1002/14651858.CD010681.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010681-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010681-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010681-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010681-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010681-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010681-abs-0001" lang="en"> <section id="CD010681-sec-0001"> <h3 class="title" id="CD010681-sec-0001">Background</h3> <p>Approximately 13% of women diagnosed with endometrial cancer present with advanced stage disease (International Federation of Gynecology and Obstetrics (FIGO) stage III/IV). The standard treatment of advanced endometrial cancer consists of cytoreductive surgery followed by radiation therapy, or chemotherapy, or both. There is currently little agreement about which adjuvant treatment is the safest and most effective. </p> </section> <section id="CD010681-sec-0002"> <h3 class="title" id="CD010681-sec-0002">Objectives</h3> <p>To evaluate the effectiveness and safety of adjuvant chemotherapy compared with radiotherapy or chemoradiation, and to determine which chemotherapy agents are most effective in women presenting with advanced endometrial cancer (FIGO stage III/IV). </p> </section> <section id="CD010681-sec-0003"> <h3 class="title" id="CD010681-sec-0003">Search methods</h3> <p>We searched the Cochrane Gynaecological Cancer Collaborative Review Group's Trial Register, the Cochrane Central Register of Controlled Trials (CENTRAL) (Issue 10 2013), MEDLINE and EMBASE up to November 2013. Also we searched electronic clinical trial registries for ongoing trials. </p> </section> <section id="CD010681-sec-0004"> <h3 class="title" id="CD010681-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) of adjuvant chemotherapy compared with radiotherapy or chemoradiation in women with FIGO stage III and IV endometrial cancer. </p> </section> <section id="CD010681-sec-0005"> <h3 class="title" id="CD010681-sec-0005">Data collection and analysis</h3> <p>Two review authors selected trials, extracted data, and assessed trials for risk of bias. Where necessary, we contacted trial investigators for relevant, unpublished data. We pooled data using the random‐effects model in Review Manager (RevMan) software. </p> </section> <section id="CD010681-sec-0006"> <h3 class="title" id="CD010681-sec-0006">Main results</h3> <p>We included four multicentre RCTs involving 1269 women with primary FIGO stage III/IV endometrial cancer. We considered the trials to be at low to moderate risk of bias. All participants received primary cytoreductive surgery. Two trials, evaluating 620 women (83% stage III, 17% stage IV), compared adjuvant chemotherapy with adjuvant radiotherapy; one trial evaluating 552 women (88% stage III, 12% stage IV) compared two chemotherapy regimens (cisplatin/doxorubicin/paclitaxel (CDP) versus cisplatin/doxorubicin (CD) treatment) in women who had all undergone adjuvant radiotherapy; and one trial contributed no data. </p> <p>Overall survival (OS) and progression‐free survival (PFS) was longer with adjuvant chemotherapy compared with adjuvant radiotherapy (OS: hazard ratio (HR) 0.75, 95% confidence interval (CI) 0.57 to 0.99, I² = 22%; and PFS: HR 0.74, 95% CI 0.59 to 0.92, I² = 0%). Sensitivity analysis using adjusted and unadjusted OS data, gave similar results. In subgroup analyses, the effects on survival in favour of chemotherapy were not different for stage III and IV, or stage IIIA and IIIC (tests for subgroup differences were not significant and I² = 0%). This evidence was of moderate quality. Data from one trial showed that women receiving adjuvant chemotherapy were more likely to experience haematological and neurological adverse events and alopecia, and more likely to discontinue treatment (33/194 versus 6/202; RR 5.73, 95% CI 2.45 to 13.36), than those receiving adjuvant radiotherapy. There was no statistically significant difference in treatment‐related deaths between the chemotherapy and radiotherapy treatment arms (8/309 versus 5/311; Risk Ratio (RR) 1.67, 95% CI 0.55 to 5.00). </p> <p>There was no clear difference in PFS between intervention groups in the one trial that compared CDP versus CD (552 women; HR 0.90, 95% CI 0.69 to 1.17). We considered this evidence to be of moderate quality. Mature OS data from this trial were not yet available. Severe haematological and neurological adverse events occurred more frequently with CDP than CD. </p> <p>We found no trials to include of adjuvant chemotherapy versus chemoradiation in advanced endometrial cancer; however we identified one ongoing trial of this comparison. </p> </section> <section id="CD010681-sec-0007"> <h3 class="title" id="CD010681-sec-0007">Authors' conclusions</h3> <p>There is moderate quality evidence that chemotherapy increases survival time after primary surgery by approximately 25% relative to radiotherapy in stage III and IV endometrial cancer. There is limited evidence that it is associated with more adverse effects. There is some uncertainty as to whether triplet regimens offer similar survival benefits over doublet regimens in the long‐term. Further research is needed to determine which chemotherapy regimen(s) are the most effective and least toxic, and whether the addition of radiotherapy further improves outcomes. A large trial evaluating the benefits and risks of adjuvant chemoradiation versus chemotherapy in advanced endometrial cancer is ongoing. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010681-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010681-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010681-abs-0011">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010681-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD010681-abs-0006">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ms#CD010681-abs-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010681-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD010681-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010681-abs-0002" lang="en"> <h3>Chemotherapy after surgery for stage III and IV endometrial cancer</h3> <p><i><b>The issue:</b> </i> Advanced endometrial cancer (FIGO stage III and IV) is cancer of the womb which has spread beyond the womb to the ovaries, vagina, other adjacent tissues, draining lymph nodes, or other organs. Women are usually treated by surgery to remove as much of the tumour as possible. They are then offered adjuvant (meaning 'added') radiotherapy (high energy x‐rays and other rays that destroy cancer cells), or chemotherapy (anti‐cancer drugs), or both. There is uncertainty as to which treatment (radio‐ or chemotherapy or both) after surgery has the greatest effect on survival, and which anti‐cancer drugs work best. </p> <p><i><b>The aim of the review:</b> </i> We aimed to determine whether chemotherapy after surgery is effective compared to radiotherapy, in women with advanced cancer of the womb. </p> <p><i><b>How was the review conducted?</b> </i> We searched the literature from 1966 to November 2013 for relevant randomised controlled trials (RCTs). We included four RCTs which were at low to moderate risk of bias and involved 1269 women. We wrote to the investigators of three trials for unpublished data. Three of the four trials compared similar interventions (chemotherapy versus radiotherapy after surgery). We pooled survival data (including the unpublished data) from two trials and await unpublished data for the third trial. The fourth trial compared two types of chemotherapy treatments after all women had received surgery and radiotherapy. </p> <p><i><b>What are the main findings?</b> </i> Women who received chemotherapy after surgery (starting within eight weeks of surgery) survived approximately 25% longer than those receiving radiotherapy after surgery. Assuming that 60% of women with stage III endometrial cancer usually survive at least five years after surgery and radiotherapy, this would increase to 75% if they receive surgery and chemotherapy instead, depending on other risk factors, such as age. The risk of death which might have been caused by treatment was low with both chemotherapy and radiotherapy but we could not be sure if one was more harmful than the other. Chemotherapy may be associated with more side‐effects (low blood counts, nerve damage and hair loss) compared with radiotherapy. </p> <p>In the trial that compared two different chemotherapy treatments, there was no clear evidence that using three anti‐cancer drugs was better than using two. However, the final overall survival results of this trial have not yet been reported. Severe side‐effects were much more common in women treated with three anti‐cancer drugs than two drugs. </p> <p><i><b>What are the conclusions?</b> </i> Chemotherapy appears to be more effective than radiotherapy after surgery for women with stage III and IV endometrial cancer but may cause more side‐effects. More research is needed to determine whether the addition of radiotherapy to chemotherapy improves outcomes and which anti‐cancer drugs are best. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010681-sec-0056" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010681-sec-0056"></div> <h3 class="title" id="CD010681-sec-0057">Implications for practice</h3> <section id="CD010681-sec-0057"> <p>There is moderate quality evidence that chemotherapy increases survival time after primary surgery by approximately 25% relative to radiotherapy in stage III and IV endometrial cancer. There is limited evidence that it is associated with more adverse effects. There is some uncertainty as to whether triplet regimens offer similar survival benefits over doublet regimens in the long‐term. Further research is needed to determine which chemotherapy regimen/s are the most effective and least toxic, and whether the addition of radiotherapy further improves outcomes. </p> </section> <h3 class="title" id="CD010681-sec-0058">Implications for research</h3> <section id="CD010681-sec-0058"> <p>Further research is needed to determine whether the addition of radiotherapy improves survival in advanced endometrial cancer and to determine what is the optimal chemotherapy regimen/s with regard to survival, safety and QoL. Further research is needed to determine if these findings are consistent in older women. </p> <p>A review of chemoradiation versus radiotherapy in advanced endometrial cancer, incorporating stage III data from the ongoing <a href="./references#CD010681-bbs2-0015" title="PORTEC-3 collaborators. Chemotherapy and radiation therapy compared with radiation therapy alone in treating patients with high-risk stage I, stage II, or stage III endometrial cancer. http://www.controlled-trials.com/mrct/trial/386235/PORTEC-32012. ">PORTEC‐3</a> trial, will be valuable. For this, reviewers would need to obtain unpublished stage III data from the ILIADE trial (<a href="./references#CD010681-bbs2-0009" title="HogbergT , RosenbergP , KristensenG , deOliveiraCF , dePont ChristensenR , SorbeB , et al. A randomized phase III study on adjuvant treatment with radiation +/- chemotherapy in early-stage high-risk endometrial cancer (NSGO-EC-9501/EORTC55991) [Abstract]. Journal of Clinical Oncology. Abstracts of the 43rd Annual Meeting of the American Society of Clinical Oncology2007;25(18 Suppl):Abstract 5503. HogbergT , SignorelliM , deOliveiraCF , FossatiR , LissoniAA , SorbeB , et al. Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studies. European Journal of Cancer2010;46(13):2422-31. ">Hogberg 2010</a>). </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010681-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010681-sec-0008"></div> <div class="table" id="CD010681-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Adjuvant chemotherapy (CT) versus adjuvant radiotherapy (RT) for women with stage III and IV endometrial cancer</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population: women with stage III or IV endometrial cancer after primary cytoreductive surgery</b> </p> <p><b>Settings: hospital</b> </p> <p><b>Intervention: CT</b> </p> <p><b>Comparison: RT</b> </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No of participants<br/>(trials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>RT</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>CT</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>5‐ year OS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Stage III</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>HR 0.75</b> (0.57 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>620 women<br/>(2) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/><b>moderate</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p>For OS, a consistent effect was demonstrated across trials and subgroups (IIIA, IIIC and IV). Dichotomous OS data gave similar results (two trials, RR 0.79, 95% CI 0.68 to 0.93). </p> <p>For PFS, a consistent effect was demonstrated across trials and subgroups (IIIA, IIIC and IV) but the dichotomous data suggests a smaller effect size (two trials, RR 0.89, 95% CI 0.77 to 1.02). We downgraded the quality of evidence due to imprecision (wide CIs) and the possibility that salvage radiotherapy may have contributed to a greater effect size for OS. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>60 women alive per 100 diagnosed</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>75 women alive per 100 diagnosed</b> (61 to 86) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Stage IV</b> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>30 women alive per 100 diagnosed</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>38 women alive per 100 diagnosed</b> (30 to 50) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>5‐year PFS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Not estimated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.74</b> (0.59 to 0.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>620 women<br/>(2) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>5‐year OS (stage III)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Not estimated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.76</b> </p> <p>(0.57 to 1.02)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>514 women</p> <p>(2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>5‐year PFS (stage III)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Not estimated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.81</b> (0.63 to 1.05) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>514 women</p> <p>(2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The <b>assumed risk</b> is based on SEER survival data (<a href="./references#CD010681-bbs2-0037" title="KosaryCL . Chapter 15: Cancer of the corpus uteri. In: Gloeckler RiesLA , YoungJL , KeelGE , EisnerMP , LinYD , Horner M-J, editors(s). Cancer survival among adults: US SEER program, 1988-2001. Patient and Tumor Characteristics. Bethesda, MD: National Cancer Institute, 2007:123-132.">SEER 2007</a>). Use of these data assumes that the adjuvant treatment of choice from 1988 to 2001 was radiotherapy. Assumed risk varies depending on other risk factors, such as age and histology. </p> <p>The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI</b> : Confidence interval; <b>HR</b> : Hazard ratio; <b>OS</b> : Overall survival; <b>PFS</b> : Progression‐free survival; <b>CT</b> : chemotherapy; <b>RT</b>: radiotherapy. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD010681-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Summary of findings</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Adjuvant cisplatin/doxorubicin/paclitaxel (CDP) compared with cisplatin/doxorubicin (CD) for women with advanced (stage III/IV) endometrial cancer</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Patient or population:</b> women with advanced (stage III/IV) endometrial cancer after surgery and radiotherapy </p> <p><b>Settings:</b> hospital </p> <p><b>Intervention: CDP</b> </p> <p><b>Comparison: CD</b> </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>No of participants<br/>(trials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PFS (stage III/IV)</b> </p> <p>Median follow‐up 46/47 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.90</b> (0.69 to 1.17) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>552<br/>(1) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We considered this evidence high quality but downgraded it to moderate, as mature OS data has not yet been published, therefore we cannot exclude other differences in survival risks/benefits. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>CI</b> : Confidence interval; <b>HR</b> : Hazard ratio; <b>PFS</b> : Progression‐free survival; <b>CDP</b> : cisplatin/doxorubicin/paclitaxel; <b>CD</b>: cisplatin/doxorubicin. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010681-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010681-sec-0009"></div> <section id="CD010681-sec-0010"> <h3 class="title" id="CD010681-sec-0010">Description of the condition</h3> <p>Endometrial cancer (cancer of the lining of the uterus) is the fifth most common cancer in women, accounting for an estimated 320,000 new cases globally each year <i>(</i><a href="./references#CD010681-bbs2-0029" title="The International Agency for Research on Cancer. GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_population.aspx2013.">IARC 2013</a>). A woman's risk of developing endometrial cancer by the age of 75 is estimated to range from 0.6% in developing countries to 1.6% in developed countries (<a href="./references#CD010681-bbs2-0031" title="JemalA , BrayF , Center MM , FerlayJ , WardE , FormanD . Global cancer statistics. CA: A Cancer Journal for Clinicians2011;61(2):69-90.">Jemal 2011</a>). Risk factors include age, obesity, diabetes mellitus, nulliparity, late menopause, unopposed oestrogen intake or oestrogen‐producing tumours, a history of breast cancer and the use of tamoxifen (<a href="./references#CD010681-bbs2-0017" title="BerekJS , HackerNF . Berek and Hacker's Gynecologic Oncology. 5th edition. Lippincott Williams &amp; Wilkins, 2010.">Berek 2010</a>). Although the incidence and mortality rates of several other cancers have plateaued or decreased over the last decade, the incidence of endometrial cancer has been rising (<a href="./references#CD010681-bbs2-0030" title="JemalA , SiegelR , WardE , HaoY , XuJ , MurrayT , et al. Cancer statistics, 2008. CA: A Cancer Journal for Clinicians2008;58(2):71-96.">Jemal 2008</a>). In the United Kingdom, the number of women with endometrial cancer has increased by over 40% since 1993 (<a href="./references#CD010681-bbs2-0024" title="EvansT , SanyO , PearmainP , GanesanR , BlannA , SundarS . Differential trends in the rising incidence of endometrial cancer by type: data from a UK population-based registry from 1994 to 2006. British Journal of Cancer2011;104(9):1505–10.">Evans 2011</a>). </p> <p>Endometrial cancer is predominantly a disease of post‐menopausal women and most common in women over 50 years of age. Only 10% to 15% of women presenting with symptoms actually harbour endometrial cancer, and the incidence of endometrial cancer in women with perimenopausal bleeding may be less than 2% (<a href="./references#CD010681-bbs2-0022" title="DubinskyTJ . Value of sonography in the diagnosis of abnormal vaginal bleeding. Journal of Clinical Ultrasound2004;32(7):348–53.">Dubinsky 2004</a>). Over 70% of women with endometrial cancer present with International Federation of Gynecology and Obstetrics (FIGO) stage I disease (<a href="./references#CD010681-bbs2-0019" title="CreasmanWT , OdicinoF , MausinneuveP , QuinnMA , BellerU , BenedetJL , et al. Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. International Journal of Gynaecology and Obstetrics2006;95(Suppl 1):S105-43.">Creasman 2006</a>), which is associated with a five‐year survival rate of greater than 90% (<a href="./references#CD010681-bbs2-0019" title="CreasmanWT , OdicinoF , MausinneuveP , QuinnMA , BellerU , BenedetJL , et al. Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. International Journal of Gynaecology and Obstetrics2006;95(Suppl 1):S105-43.">Creasman 2006</a>). Only a small proportion of women (13%) present with advanced disease, with five‐year survival rates of around 60% and 30% for stage III and IV, respectively, which decrease with advancing age (<a href="./references#CD010681-bbs2-0037" title="KosaryCL . Chapter 15: Cancer of the corpus uteri. In: Gloeckler RiesLA , YoungJL , KeelGE , EisnerMP , LinYD , Horner M-J, editors(s). Cancer survival among adults: US SEER program, 1988-2001. Patient and Tumor Characteristics. Bethesda, MD: National Cancer Institute, 2007:123-132.">SEER 2007</a>). </p> <p>The standard surgical treatment of women with endometrial cancer includes the removal of the uterus, both fallopian tubes and ovaries (total hysterectomy and bilateral salpingo‐oophorectomy), with or without lymphadenectomy (<a href="./references#CD010681-bbs2-0018" title="ColomboN , PretiE , LandoniF , CarinelliS , ColomboA , MariniC , et al. Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology2011;22(Suppl 6):vi35-39.">Colombo 2011</a>). Although pelvic and paraaortic lymphadenectomy is not recommended in stage I disease, in other stages it is valuable in determining a woman's prognosis and in tailoring additional treatment (<a href="./references#CD010681-bbs2-0018" title="ColomboN , PretiE , LandoniF , CarinelliS , ColomboA , MariniC , et al. Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology2011;22(Suppl 6):vi35-39.">Colombo 2011</a>). After surgery, a woman may be offered radiation therapy, or platinum‐based chemotherapy, or both, depending on her risk factors (including advanced age, grade 3, lymphovascular space invasion and bulky disease) and the stage of the disease (<a href="./references#CD010681-bbs2-0018" title="ColomboN , PretiE , LandoniF , CarinelliS , ColomboA , MariniC , et al. Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology2011;22(Suppl 6):vi35-39.">Colombo 2011</a>). </p> <p>Treatment of advanced disease (Stage III and IV) is individualized and usually involves a combination of cytoreductive surgery (CRS), radiotherapy, or chemotherapy (<a href="./references#CD010681-bbs2-0017" title="BerekJS , HackerNF . Berek and Hacker's Gynecologic Oncology. 5th edition. Lippincott Williams &amp; Wilkins, 2010.">Berek 2010</a>), or both. Complete cytoreduction, leaving no gross residual disease, is the aim of CRS and is associated with a superior overall survival compared with sub‐optimal cytoreduction (<a href="./references#CD010681-bbs2-0016" title="BarlinJN , PuriI , BristowRE . Cytoreductive surgery for advanced or recurrent endometrial cancer: a meta-analysis. Gynecologic Oncology2010;118(1):14-8.">Barlin 2010</a>). Treatment of metastatic disease is dictated by the site of the metastases and the associated symptoms (<a href="./references#CD010681-bbs2-0017" title="BerekJS , HackerNF . Berek and Hacker's Gynecologic Oncology. 5th edition. Lippincott Williams &amp; Wilkins, 2010.">Berek 2010</a>). </p> <p>If the tumour is not amenable to surgery, (non‐adjuvant) chemotherapy may be given with the aim of palliating symptoms, improving quality of life (QoL), delaying progression of disease and extending survival (<a href="./references#CD010681-bbs2-0028" title="HumberCE , TierneyJF , SymondsRP , CollingwoodM , KirwanJ , WilliamsC , et al. Chemotherapy for advanced, recurrent or metastatic endometrial cancer: a systematic review of Cochrane Collaboration. Annals of Oncology2007;18(3):409–20.">Humber 2007</a>). According to a recent Cochrane review of non‐adjuvant chemotherapy for advanced, recurrent or metastatic disease, the use of 'more chemotherapy' compared with 'less chemotherapy' is associated with a longer survival (<a href="./references#CD010681-bbs2-0038" title="ValeCL , TierneyJ , BullSJ , SymondsPR . Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma. Cochrane Database of Systematic Reviews2012, Issue 8. Art. No: CD003915. [DOI: 10.1002/14651858.CD003915.pub4]">Vale 2012</a>). Current evidence does not support the use of hormonal therapy in endometrial cancer at any stage (<a href="./references#CD010681-bbs2-0033" title="KokkaF , BrockbankE , OramD , GallagherC , BryantA . Hormonal therapy in advanced or recurrent endometrial cancer. Cochrane Database of Systematic Reviews2010, Issue 12. Art. No: CD007926. [DOI: 10.1002/14651858.CD007926.pub2]">Kokka 2010</a>; <a href="./references#CD010681-bbs2-0034" title="Martin-HirschPPL , BryantA , KeepSL , KitchenerHC , LilfordR . Adjuvant progestagens for endometrial cancer. Cochrane Database of Systematic Reviews2011, Issue 6. Art. No: CD001040. [DOI: 10.1002/14651858.CD001040.pub2]">Martin‐Hirsch 2011</a>). </p> </section> <section id="CD010681-sec-0011"> <h3 class="title" id="CD010681-sec-0011">Description of the intervention</h3> <p>Until recently, endometrial cancer was considered a relatively chemoresistant tumour and, as such, radiotherapy was the preferred adjuvant treatment, with chemotherapy reserved as salvage therapy for progressive disease (<a href="./references#CD010681-bbs2-0035" title="McMeekinDS . Where is the future of endometrial cancer therapy?Annals of Oncology2009;20(11):1757-61.">McMeekin 2009</a>). However, it is now known that doxorubicin, platinum drugs and paclitaxel all have activity against endometrial cancer (<a href="./references#CD010681-bbs2-0035" title="McMeekinDS . Where is the future of endometrial cancer therapy?Annals of Oncology2009;20(11):1757-61.">McMeekin 2009</a>). Although adjuvant chemotherapy regimens usually consist of a platinum drug combined with doxorubicin or paclitaxel, the optimal drug combination/regimen is yet to be established. In addition, the relative survival effects of adjuvant chemotherapy, or chemoradiation, or both, for advanced disease have not been elucidated. </p> </section> <section id="CD010681-sec-0012"> <h3 class="title" id="CD010681-sec-0012">Why it is important to do this review</h3> <p>In a review of adjuvant chemotherapy in endometrial cancer at any stage, <a href="./references#CD010681-bbs2-0032" title="JohnsonN , BryantA , MilesT , HogbergT , CornesP . Adjuvant chemotherapy for endometrial cancer after hysterectomy. Cochrane Database of Systematic Reviews2011, Issue 10. Art. No: CD003175. [DOI: 10.1002/14651858.CD003175.pub2]">Johnson 2011</a> concluded that platinum‐based chemotherapy may be used as an alternative or addition to radiotherapy. However, there is little agreement on what should be the standard adjuvant treatment of stage III and IV endometrial cancer. The European Society of Medical Oncologists (ESMO) recommends adjuvant chemotherapy for stage III and IV disease, with sequential radiotherapy if lymph nodes are positive (<a href="./references#CD010681-bbs2-0018" title="ColomboN , PretiE , LandoniF , CarinelliS , ColomboA , MariniC , et al. Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology2011;22(Suppl 6):vi35-39.">Colombo 2011</a>). In this systematic review, we aimed to evaluate the evidence from RCTs regarding the benefits and risks of adjuvant chemotherapy for advanced (stage III and IV) disease. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010681-sec-0013" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010681-sec-0013"></div> <p>In women with primary advanced endometrial cancer (FIGO stage III/IV):</p> <p> <ol id="CD010681-list-0001"> <li> <p>To evaluate the effectiveness and safety of adjuvant chemotherapy compared with adjuvant radiotherapy or chemoradiation; </p> </li> <li> <p>To determine which type(s) of chemotherapy agents are most effective.</p> </li> </ol> </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010681-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010681-sec-0014"></div> <section id="CD010681-sec-0015"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010681-sec-0016"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs).</p> </section> <section id="CD010681-sec-0017"> <h4 class="title">Types of participants</h4> <p>Adult women (18 years of age or older) diagnosed with advanced endometrial cancer (FIGO stage III/IV) who underwent cytoreductive surgery (CRS) as part of the management of their disease. </p> </section> <section id="CD010681-sec-0018"> <h4 class="title">Types of interventions</h4> <p>For comparison of treatment modalities:</p> <p> <ol id="CD010681-list-0002"> <li> <p>Adjuvant chemotherapy versus adjuvant radiotherapy;</p> </li> <li> <p>Adjuvant chemotherapy versus a different adjuvant chemotherapy regimen;</p> </li> <li> <p>Adjuvant chemotherapy versus adjuvant chemoradiation</p> </li> </ol> </p> </section> <section id="CD010681-sec-0019"> <h4 class="title">Types of outcome measures</h4> <section id="CD010681-sec-0020"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD010681-list-0003"> <li> <p>Overall survival (death from all causes; OS) from the time that women were enrolled in the trial. </p> </li> </ul> </p> </section> <section id="CD010681-sec-0021"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD010681-list-0004"> <li> <p>Progression‐free survival (PFS);</p> </li> <li> <p>Quality of life (QoL);</p> </li> <li> <p>Adverse events (<a href="./references#CD010681-bbs2-0020" title="Common terminology criteria for adverse events v3.0 (CTCAE). http://ctep.cancer.gov/forms/CTCAEv3.pdf2006.">CTCAE 2006</a>), including: </p> </li> </ul> </p> <p> <ul class="plain" id="CD010681-list-0005"> <li> <ul id="CD010681-list-0006"> <li> <p>Direct surgical morbidity (e.g. death within 30 days; injury to bladder, ureter, vascular, small bowel or colon), presence and complications of adhesions, febrile morbidity, intestinal obstruction, haematoma, local infection). </p> </li> <li> <p>Surgically‐related systemic morbidity (chest infection, thromboembolic events, cardiac events, cerebrovascular accidents). </p> </li> <li> <p>Recovery events: delayed discharge, unscheduled re‐admission.</p> </li> <li> <p>Adjuvant therapy toxicity.</p> </li> <li> <p>Treatment discontinuation due to refusal or toxicity.</p> </li> </ul> </li> </ul> </p> <p>We extracted and grouped data on the number of participants with severe chemotherapeutic and radiotherapeutic toxicity (<a href="./references#CD010681-bbs2-0020" title="Common terminology criteria for adverse events v3.0 (CTCAE). http://ctep.cancer.gov/forms/CTCAEv3.pdf2006.">CTCAE 2006</a> Grade 3‐5), including the following: </p> <p> <ul id="CD010681-list-0007"> <li> <p>haematological (leucopaenia, anaemia, thrombocytopenia, neutropenia, haemorrhage);</p> </li> <li> <p>gastrointestinal (nausea, vomiting, anorexia, diarrhoea, liver, proctitis);</p> </li> <li> <p>genitourinary;</p> </li> <li> <p>skin (stomatitis, mucositis, alopecia, allergy);</p> </li> <li> <p>neurological (peripheral and central); and</p> </li> <li> <p>pulmonary.</p> </li> </ul> </p> </section> </section> </section> <section id="CD010681-sec-0022"> <h3 class="title">Search methods for identification of studies</h3> <p>We sought publications in all languages and performed translations if necessary.</p> <section id="CD010681-sec-0023"> <h4 class="title">Electronic searches</h4> <p>See the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/gynaeca/frame.html" target="_blank">Cochrane Gynaecological Cancer Group</a> methods used in reviews.<br/>We searched the following electronic databases until November 2013: </p> <p> <ul id="CD010681-list-0008"> <li> <p>The Cochrane Gynaecological Cancer Collaborative Review Group's Trial Register;</p> </li> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL), Issue 10, 2013;</p> </li> <li> <p>MEDLINE to November 2013;</p> </li> <li> <p>EMBASE to November 2013.</p> </li> </ul> </p> <p>We presented the MEDLINE, EMBASE and CENTRAL search strategies based on terms related to the review topic in <a href="./appendices#CD010681-sec-0062">Appendix 1</a>, <a href="./appendices#CD010681-sec-0063">Appendix 2</a> and <a href="./appendices#CD010681-sec-0064">Appendix 3</a>, respectively. </p> <p>We identified all relevant articles on PubMed, and by using the 'related articles' feature, we performed a further search for newly published articles. </p> </section> <section id="CD010681-sec-0024"> <h4 class="title">Searching other resources</h4> <p>We searched <a href="http://www.controlled-trials.com/rct" target="_blank">www.controlled-trials.com/rct</a>, <a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>, <a href="http://www.cancer.gov/clinicaltrials" target="_blank">www.cancer.gov/clinicaltrials</a> and Gynaecologic Oncologists of Canada (<a href="http://www.g-o-c.org" target="_blank">http://www.g-o-c.org</a>) for ongoing trials. We handsearched reference lists of included trials and used the 'related citations' feature of PubMed to identify any other relevant trials. </p> </section> </section> <section id="CD010681-sec-0025"> <h3 class="title" id="CD010681-sec-0025">Data collection and analysis</h3> <section id="CD010681-sec-0026"> <h4 class="title">Selection of studies</h4> <p>We downloaded all titles and abstracts retrieved by electronic searching to the reference management database ENDNOTE (<a href="./references#CD010681-bbs2-0023" title="ENDNOTE X7.0.2. Thomson Reuters, 2013.">ENDNOTE X7.0.2</a>) and removed duplicates. Two review authors (TAL, KG) examined the remaining references independently. We excluded trials that did not meet the inclusion criteria and obtained full text of potentially relevant references. Two review authors (KG, TAL) assessed the eligibility of retrieved papers independently. We resolved disagreements by discussion between two review authors (KG, TAL) or by appeal to a third review author (AB). We documented reasons for exclusion.  </p> </section> <section id="CD010681-sec-0027"> <h4 class="title">Data extraction and management</h4> <p>For included trials, we extracted data as recommended in Chapter 7 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010681-bbs2-0027" title="HigginsJPT , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>), including data on the following: </p> <p> <ul id="CD010681-list-0009"> <li> <p>Author, year of publication and journal citation (including language);</p> </li> <li> <p>Country;</p> </li> <li> <p>Setting;</p> </li> <li> <p>Inclusion and exclusion criteria;</p> </li> <li> <p>Trial design, methodology;</p> </li> <li> <p>Trial population:</p> <ul id="CD010681-list-0010"> <li> <p>Total number enrolled</p> </li> <li> <p>Participant characteristics</p> </li> <li> <p>Age</p> </li> <li> <p>Comorbidities;</p> </li> </ul> </li> <li> <p>Endometrial cancer details at diagnosis:</p> <ul id="CD010681-list-0011"> <li> <p>FIGO stage</p> </li> <li> <p>Histological cell type</p> </li> <li> <p>Tumour grade</p> </li> <li> <p>Extent of disease</p> </li> <li> <p>Disease‐free interval</p> </li> <li> <p>Number of recurrences;</p> </li> </ul> </li> <li> <p>Total number of intervention groups;</p> </li> <li> <p>Intervention details:</p> <ul id="CD010681-list-0012"> <li> <p>Treatment modalities</p> </li> <li> <p>Details of surgery</p> </li> <li> <p>Type of surgeon (gynaeoncologist, gynaecologist, general surgeon)</p> </li> <li> <p>Experience of surgeon</p> </li> <li> <p>Details of chemotherapy, or radiotherapy, or both;</p> <ul id="CD010681-list-0013"> <li> <p>Dose</p> </li> <li> <p>Cycle length</p> </li> <li> <p>Combination</p> </li> </ul> </li> <li> <p>Details of best supportive care;</p> </li> </ul> </li> <li> <p>Risk of bias in trial (see below);</p> </li> <li> <p>Duration of follow‐up;</p> </li> <li> <p>Outcomes－OS, PFS, QoL, adverse events and treatment discontinuation due to toxicity or refusal </p> <ul id="CD010681-list-0014"> <li> <p>For each outcome: outcome definition (with diagnostic criteria if relevant)</p> </li> <li> <p>Unit of measurement (if relevant)</p> </li> <li> <p>For scales: upper and lower limits and whether high or low score is good</p> </li> <li> <p>Results: number of participants allocated to each intervention group</p> </li> <li> <p>For each outcome of interest: sample size and missing participants.</p> </li> </ul> </li> </ul> </p> <p>We extracted data on outcomes as below:</p> <p> <ul id="CD010681-list-0015"> <li> <p>For time‐to‐event data, we extracted the log of the hazard ratio [log(HR)] and its standard error (SE) from trial reports; </p> </li> <li> <p>For dichotomous outcomes (adverse events), we extracted the number of participants in each group who experienced the outcome of interest and the number of participants assessed at endpoint to estimate a risk ratio (RR). </p> </li> </ul> </p> <p>Where possible, we extracted all data relevant to an intention‐to‐treat (ITT) analysis in which participants were analysed in groups to which they were assigned. We recorded the time points at which outcomes were collected and reported. Two review authors (KG, TAL) extracted data independently using a pre‐designed data collection form. We resolved differences between review authors by discussion or by appeal to a third review author (AB) when necessary. </p> </section> <section id="CD010681-sec-0028"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We assessed the risk of bias of included RCTs in accordance with guidelines in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> using the Cochrane Collaboration's tool and the criteria specified in Chapter 8 (<a href="./references#CD010681-bbs2-0027" title="HigginsJPT , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). This included assessment of: </p> <p> <ul id="CD010681-list-0016"> <li> <p>sequence generation;</p> </li> <li> <p>allocation concealment;</p> </li> <li> <p>blinding (restricted to blinding of outcome assessors as not possible to blind participants and health care providers to surgical intervention); </p> </li> <li> <p>incomplete outcome data:</p> <ul id="CD010681-list-0017"> <li> <p>We recorded the proportions of participants whose outcomes were not reported at the end of the trial. We coded the satisfactory level of loss to follow‐up for each outcome as follows: </p> <ul id="CD010681-list-0018"> <li> <p>Yes, if fewer than 20% of participants were lost to follow‐up and reasons for loss to follow‐up were similar in both treatment arms; </p> </li> <li> <p>No, if more than 20% of participants were lost to follow‐up or reasons for loss to follow‐up were different between treatment arms; and </p> </li> <li> <p>Unclear, if loss to follow‐up was not reported.</p> </li> </ul> </li> </ul> </li> <li> <p>selective reporting of outcomes; and</p> </li> <li> <p>other possible sources of bias.</p> </li> </ul> </p> <p>Two review authors (KG, TAL) applied the risk of bias tool independently and we resolved differences by discussion or by appeal to a third reviewer (AB). We summarised results in a risk of bias summary (<a href="#CD010681-fig-0001">Figure 1</a>) and interpreted results of meta‐analyses in light of the findings with respect to risk of bias. </p> <div class="figure" id="CD010681-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included trial." data-id="CD010681-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-FIG-01.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included trial. </p> </div> </div> </div> </section> <section id="CD010681-sec-0029"> <h4 class="title">Measures of treatment effect</h4> <p>We used the following measures of the effect of treatment:</p> <p> <ul id="CD010681-list-0019"> <li> <p>For time‐to‐event data, we used the hazard ratio (HR) to compare the risk of death or disease progression in the treatment group with that in the control group; </p> </li> <li> <p>For dichotomous outcomes (adverse events), we used the risk ratio (RR).</p> </li> </ul> </p> </section> <section id="CD010681-sec-0030"> <h4 class="title">Dealing with missing data</h4> <p>We did not impute missing outcome data for any of the outcomes. We contacted trial authors if data were missing or if only imputed data were reported to request data on outcomes only among participants who were assessed. </p> </section> <section id="CD010681-sec-0031"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed statistical heterogeneity between trials by visual inspection of forest plots, by estimation of the percentage heterogeneity between trials that cannot be ascribed to sampling variation (<a href="./references#CD010681-bbs2-0026" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta-analyses. BMJ2003;327(7414):557-60.">Higgins 2003</a>) and by a formal statistical test of the significance of the heterogeneity (<a href="./references#CD010681-bbs2-0021" title="DeeksJJ , AltmanDG , BradburnMJ . Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: In: Egger M, Davey Smith G, Altman DG, editor(s). Systematic Reviews in Health Care: Meta-Analysis in Context. 2nd edition. London: BMJ Publication Group, 2001.">Deeks 2001</a>). We considered statistical heterogeneity between trials to be substantial if, following meta‐analysis, I² was greater than 30% and either T² is greater than zero, or there was a low P value (&lt; 0.10) in the Chi² test for heterogeneity. We used the random‐effects model for all meta‐analyses. </p> </section> <section id="CD010681-sec-0032"> <h4 class="title">Assessment of reporting biases</h4> <p>There was an insufficient number of trials for an adequate assessment of small trial biases such as publication bias. </p> </section> <section id="CD010681-sec-0033"> <h4 class="title">Data synthesis</h4> <p>We pooled the results in meta‐analyses where possible using adjusted summary statistics and the random‐effects model. </p> <p> <ul id="CD010681-list-0020"> <li> <p>For time‐to‐event data, we pooled HRs using the generic inverse variance facility of <a href="./references#CD010681-bbs2-0036" title="The Nordic Cochrane Centre, The Cochrane CollaborationReview Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.">Review Manager (RevMan)</a>; </p> </li> <li> <p>For dichotomous outcomes, we pooled RRs.</p> </li> </ul> </p> </section> <section id="CD010681-sec-0034"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We obtained unpublished data where possible and performed subgroup analysis according to stage for the comparison 'adjuvant chemotherapy versus adjuvant radiotherapy'. Where possible, we considered other risk factors such as age, stage, grade, histology, type of chemotherapy regimen used and length of follow‐up to assess clinical heterogeneity. We performed exploratory meta‐analyses of stage III sub‐stages IIIA and IIIC. The sample size of the stage IIIB sub‐stage was insufficient for meta‐analysis. </p> </section> <section id="CD010681-sec-0035"> <h4 class="title">Sensitivity analysis</h4> <p>Where possible, we performed sensitivity analysis using adjusted and unadjusted overall data for the primary outcomes. This was possible for overall survival only. In addition, we performed meta‐analyses of dichotomous survival data for OS and PFS. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010681-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010681-sec-0036"></div> <section id="CD010681-sec-0037"> <h3 class="title">Description of studies</h3> <section id="CD010681-sec-0038"> <h4 class="title">Results of the search</h4> <p>We identified 1473 citations, which reduced to 599 after we removed duplicates and irrelevant citations. We identified 57 records for screening, which resulted in 17 full text articles (pertaining to 13 trials) for classification (<a href="#CD010681-fig-0002">Figure 2</a>). Following examination of the full text articles, we included four trials (seven reports) and excluded nine trials (ten reports). In addition, we identified two ongoing trials (<a href="./references#CD010681-bbs2-0014" title="Gynecologic Oncology Group. Carboplatin and paclitaxel with or without cisplatin and radiation therapy in treating patients with stage I, stage II, stage III, or stage IVA endometrial cancer. http://www.controlled-trials.com/mrct/trial/587551/endometrial+cancer (accessed 11 November 2013). ">GOG 0258</a>; <a href="./references#CD010681-bbs2-0015" title="PORTEC-3 collaborators. Chemotherapy and radiation therapy compared with radiation therapy alone in treating patients with high-risk stage I, stage II, or stage III endometrial cancer. http://www.controlled-trials.com/mrct/trial/386235/PORTEC-32012. ">PORTEC‐3</a>). </p> <div class="figure" id="CD010681-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD010681-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-FIG-02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD010681-sec-0039"> <h4 class="title">Included studies</h4> <p>We included four trials:</p> <p> <ul id="CD010681-list-0021"> <li> <p><a href="./references#CD010681-bbs2-0001" title="BrunerDW , BarsevickA , TianC , RandallM , MannelR , CohnDE , et al. Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: A Gynecologic Oncology Group study. Quality of Life Research2007;16(1):89-100. RandallME , FiliaciVL , MussH , SpirtosNM , MannelRS , FowlerJ , et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. Journal of Clinical Oncology2006;24(1):36-44. TewariKS , FiliaciVL , SpirtosNM , MannelRS , ThigpenJT , CibullML , et al. Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: a Gynecologic Oncology Group study. Gynecologic Oncology2012;125(1):87-93. ">GOG 122</a>: a RCT of adjuvant chemotherapy versus whole body irradiation in women with stage III and IV endometrial cancer within eight weeks of CRS; </p> </li> <li> <p><a href="./references#CD010681-bbs2-0002" title="HomesleyHD , FiliaciV , GibbonsSK , LongHJ , CellaD , SpirtosNM , et al. A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study. Gynecologic Oncology2009;112(3):543-52. ">GOG 184</a>: a RCT comparing two different adjuvant chemotherapy regimens in women with stage III and IV endometrial cancer following CRS and radiotherapy; </p> </li> <li> <p><a href="./references#CD010681-bbs2-0003" title="MaggiR , LissoniA , SpinaF , MelpignanoM , ZolaP , FavalliG , et al. Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. British Journal of Cancer2006;95(3):266-71. ">Maggi 2006</a>: a RCT comparing adjuvant chemotherapy versus pelvic external beam radiotherapy in women with high‐risk (stage IC G3 to III) endometrial cancer within 30 days of surgery. As this trial included a significant proportion of stage III patients (64%), we requested separate stage III data from the investigators; </p> </li> <li> <p><a href="./references#CD010681-bbs2-0004" title="SusumuN , SagaeS , UdagawaY , NiwaK , KuramotoH , SatohS , et al. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecologic Oncology2008;108(1):226-33. ">Susumu 2008</a>: a RCT comparing adjuvant chemotherapy versus pelvic external beam radiotherapy in women with high‐risk (stage IC G3 to III) endometrial cancer within four weeks of surgery. As this trial comprised 25% of stage III patients, we requested separate stage III data from the investigators. </p> </li> </ul> </p> <p>Both <a href="./references#CD010681-bbs2-0001" title="BrunerDW , BarsevickA , TianC , RandallM , MannelR , CohnDE , et al. Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: A Gynecologic Oncology Group study. Quality of Life Research2007;16(1):89-100. RandallME , FiliaciVL , MussH , SpirtosNM , MannelRS , FowlerJ , et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. Journal of Clinical Oncology2006;24(1):36-44. TewariKS , FiliaciVL , SpirtosNM , MannelRS , ThigpenJT , CibullML , et al. Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: a Gynecologic Oncology Group study. Gynecologic Oncology2012;125(1):87-93. ">GOG 122</a> and <a href="./references#CD010681-bbs2-0002" title="HomesleyHD , FiliaciV , GibbonsSK , LongHJ , CellaD , SpirtosNM , et al. A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study. Gynecologic Oncology2009;112(3):543-52. ">GOG 184</a> were multicentre, parallel RCTs conducted in the USA. <a href="./references#CD010681-bbs2-0001" title="BrunerDW , BarsevickA , TianC , RandallM , MannelR , CohnDE , et al. Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: A Gynecologic Oncology Group study. Quality of Life Research2007;16(1):89-100. RandallME , FiliaciVL , MussH , SpirtosNM , MannelRS , FowlerJ , et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. Journal of Clinical Oncology2006;24(1):36-44. TewariKS , FiliaciVL , SpirtosNM , MannelRS , ThigpenJT , CibullML , et al. Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: a Gynecologic Oncology Group study. Gynecologic Oncology2012;125(1):87-93. ">GOG 122</a> enrolled 422 women with FIGO stage III or IV endometrial cancer of any histology, of whom 396 were evaluable. Pre‐randomisation CRS included total abdominal hysterectomy (TAH) and bilateral salpingo‐oophorectomy (BSO), surgical staging and tumour resection to a maximum of 2 cm residual tumour at a single site. Women commenced adjuvant treatment within eight weeks of CRS. Participants' baseline characteristics were: 50% endometrioid tumours; 27% stage IV; 52% grade 3; 86% microscopic residual disease; 95% performance status 0‐1; and median age 63 years. Risk factors for poorer prognosis were slightly skewed in favour of the WAI arm and results were adjusted for these risk factors in the trial analyses. Median follow‐up was 74 months overall. Outcomes assessed included OS, PFS, adverse events and QoL. <a href="./references#CD010681-bbs2-0001" title="BrunerDW , BarsevickA , TianC , RandallM , MannelR , CohnDE , et al. Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: A Gynecologic Oncology Group study. Quality of Life Research2007;16(1):89-100. RandallME , FiliaciVL , MussH , SpirtosNM , MannelRS , FowlerJ , et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. Journal of Clinical Oncology2006;24(1):36-44. TewariKS , FiliaciVL , SpirtosNM , MannelRS , ThigpenJT , CibullML , et al. Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: a Gynecologic Oncology Group study. Gynecologic Oncology2012;125(1):87-93. ">GOG 122</a> compared QoL between intervention arms using the Fatigue Scale (FS), Assessment of Peripheral Neuropathy (APN), Functional Alterations due to Changes in Elimination (FACE) and Functional Assessment of Cancer Therapy ‐ General (FACT‐G). Baseline data were obtained for 317/396 women (80%) and "70 to 80%" of living patients completed QoL assessments at three month and six month time points. </p> <p><a href="./references#CD010681-bbs2-0002" title="HomesleyHD , FiliaciV , GibbonsSK , LongHJ , CellaD , SpirtosNM , et al. A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study. Gynecologic Oncology2009;112(3):543-52. ">GOG 184</a> enrolled 586 women, of whom 552 were evaluated. Women were eligible if they had FIGO stage III or IV endometrial cancer of any histology, with disease limited to the pelvis and abdomen. Pre‐randomisation treatment included CRS (at least a hysterectomy and BSO) and radiotherapy. The interventions compared were cisplatin, doxorubicin and paclitaxel versus cisplatin and doxorubicin, every three weeks for six cycles. After the results of <a href="./references#CD010681-bbs2-0001" title="BrunerDW , BarsevickA , TianC , RandallM , MannelR , CohnDE , et al. Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: A Gynecologic Oncology Group study. Quality of Life Research2007;16(1):89-100. RandallME , FiliaciVL , MussH , SpirtosNM , MannelRS , FowlerJ , et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. Journal of Clinical Oncology2006;24(1):36-44. TewariKS , FiliaciVL , SpirtosNM , MannelRS , ThigpenJT , CibullML , et al. Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: a Gynecologic Oncology Group study. Gynecologic Oncology2012;125(1):87-93. ">GOG 122</a> were known, women with stage IV were no longer eligible as <a href="./references#CD010681-bbs2-0001" title="BrunerDW , BarsevickA , TianC , RandallM , MannelR , CohnDE , et al. Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: A Gynecologic Oncology Group study. Quality of Life Research2007;16(1):89-100. RandallME , FiliaciVL , MussH , SpirtosNM , MannelRS , FowlerJ , et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. Journal of Clinical Oncology2006;24(1):36-44. TewariKS , FiliaciVL , SpirtosNM , MannelRS , ThigpenJT , CibullML , et al. Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: a Gynecologic Oncology Group study. Gynecologic Oncology2012;125(1):87-93. ">GOG 122</a> showed a statistically significant benefit in PFS with adjuvant chemotherapy compared with adjuvant radiotherapy in stage IV disease. Therefore, the proportion of stage IV women enrolled in this trial was less than in <a href="./references#CD010681-bbs2-0001" title="BrunerDW , BarsevickA , TianC , RandallM , MannelR , CohnDE , et al. Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: A Gynecologic Oncology Group study. Quality of Life Research2007;16(1):89-100. RandallME , FiliaciVL , MussH , SpirtosNM , MannelRS , FowlerJ , et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. Journal of Clinical Oncology2006;24(1):36-44. TewariKS , FiliaciVL , SpirtosNM , MannelRS , ThigpenJT , CibullML , et al. Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: a Gynecologic Oncology Group study. Gynecologic Oncology2012;125(1):87-93. ">GOG 122</a>. Baseline characteristics for <a href="./references#CD010681-bbs2-0002" title="HomesleyHD , FiliaciV , GibbonsSK , LongHJ , CellaD , SpirtosNM , et al. A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study. Gynecologic Oncology2009;112(3):543-52. ">GOG 184</a> were: 69% endometrioid tumours; 12% stage IV; 41% grade 3; 90% absent or microscopic residual disease; 99% performance status 0‐1; and median age 58 years. Median follow‐up was 47 and 46 months for the trial arms, respectively. Outcomes assessed included recurrence ‐free survival (RFS) (three year), OS, loco‐regional recurrence, distant recurrence, and adverse events. Peripheral neuropathy was measured using the Functional Assessment of Cancer Therapy ‐ Neurotoxicity (FACT‐N) at baseline, four weeks and six months after chemotherapy. The trial authors included women who completed follow‐up assessments (422/552) in the analysis. Overall survival has not yet been reported for this trial and we were unable to obtain mature, unpublished data from the investigators. </p> <p><a href="./references#CD010681-bbs2-0003" title="MaggiR , LissoniA , SpinaF , MelpignanoM , ZolaP , FavalliG , et al. Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. British Journal of Cancer2006;95(3):266-71. ">Maggi 2006</a> was a multicentre, parallel RCT conducted in Italy. <a href="./references#CD010681-bbs2-0003" title="MaggiR , LissoniA , SpinaF , MelpignanoM , ZolaP , FavalliG , et al. Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. British Journal of Cancer2006;95(3):266-71. ">Maggi 2006</a> included women with stages IC G3 to III disease (N = 345). We obtained separate, unpublished stage III data (N = 224) from the <a href="./references#CD010681-bbs2-0003" title="MaggiR , LissoniA , SpinaF , MelpignanoM , ZolaP , FavalliG , et al. Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. British Journal of Cancer2006;95(3):266-71. ">Maggi 2006</a> investigators, facilitating our inclusion of this trial. In <a href="./references#CD010681-bbs2-0003" title="MaggiR , LissoniA , SpinaF , MelpignanoM , ZolaP , FavalliG , et al. Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. British Journal of Cancer2006;95(3):266-71. ">Maggi 2006</a> randomisation was stratified by stage of disease, with approximately 26.5% stage I, 9% stage II and 64% stage III disease, therefore we included only the stage III data from this trial in our meta‐analyses. The chemotherapy arm received cisplatin, doxorubicin and cyclophosphamide every 28 days for five cycles. Women commenced adjuvant treatment within 30 days of CRS. Overall baseline characteristics, which were similar for both intervention groups, were: 57% grade 3, 72% myometrial invasion &gt; 50%, median age 62.5 years. All participants underwent CRS, 93% of whom had a TAH and BSO; however, the percentage with residual disease was not reported. Median follow‐up was 95.5 months. Outcomes assessed included 3‐, 5‐, and 7‐year OS, PFS and adverse events. </p> <p><a href="./references#CD010681-bbs2-0004" title="SusumuN , SagaeS , UdagawaY , NiwaK , KuramotoH , SatohS , et al. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecologic Oncology2008;108(1):226-33. ">Susumu 2008</a> was a multicentre, parallel RCT conducted in Japan. Women with endometrial cancer FIGO stages IC to III were evaluated (N = 385 analysed), including 97 women with stage III disease. Randomisation was not stratified by stage of disease. We requested separate data from the trial investigators for the stage III subgroup. The chemotherapy arm received cisplatin, doxorubicin and cyclophosphamide every 28 days for three to seven cycles. Women commenced adjuvant treatment within four weeks of CRS. Overall baseline characteristics were similar for both intervention groups: all women had endometrioid histology and no residual disease, 53% had grade 3 lesions, 100% had myometrial invasion &gt; 50%, and the mean age was 59 years. Pelvic lymphadenopathy was performed in 96% and paraaortic lymphadenopathy was performed in 29% of participants. Median follow‐up was approximately 60 months and outcomes assessed were five‐year OS, PFS and toxicity. </p> </section> <section id="CD010681-sec-0040"> <h4 class="title">Excluded studies</h4> <p>We excluded nine studies for the following reasons:</p> <p> <ul id="CD010681-list-0022"> <li> <p>Study intervention was not eligible (non‐adjuvant chemotherapy) (<a href="./references#CD010681-bbs2-0005" title="AaproMS , vanWijkFH , BolisG , ChevallierB , van derBurgME , PovedaA , et al. Doxurubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group. Annals of Oncology2003;14(3):441-8. ">Aapro 2003</a>; <a href="./references#CD010681-bbs2-0006" title="FlemingGF , FiliaciVL , BentleyRC , HerzogT , SoroskyJ , VaccarelloL , et al. Phase III randomized trial of doxorubicin + cisplatin versus doxorubicin + 24-h paclitaxel + filgrastim in endometrial carcinoma: a Gynecologic Oncology Group study. Annals of Oncology2004;15(8):1173-8. ">Fleming 2004a</a>; <a href="./references#CD010681-bbs2-0007" title="FlemingGF , BrunettoVL , CellaD , LookKY , ReidGC , MunkarahAR , et al. Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. Journal of Clinical Oncology2004;22(11):2159-66. ">Fleming 2004b</a>; <a href="./references#CD010681-bbs2-0008" title="GallionHH , BrunettoVL , CibullM , LentzSS , ReidG , SoperJT , et al. Randomized phase III trial of standard timed doxorubicin plus cisplatin versus circadian timed doxorubicin plus cisplatin in stage III and IV or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study. Journal of Clinical Oncology2003;21(20):3808-13. ">Gallion 2003</a>; <a href="./references#CD010681-bbs2-0012" title="NomuraH , AokiD , TakahashiF , KatsumataN , WatanabeY , KonishiI , et al. Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic Oncology Group study (JGOG2041). Annals of Oncology2011;22(3):636-42. ">Nomura 2011</a>); </p> </li> <li> <p>Study comparison was not eligible (radiotherapy versus chemoradiation) (<a href="./references#CD010681-bbs2-0009" title="HogbergT , RosenbergP , KristensenG , deOliveiraCF , dePont ChristensenR , SorbeB , et al. A randomized phase III study on adjuvant treatment with radiation +/- chemotherapy in early-stage high-risk endometrial cancer (NSGO-EC-9501/EORTC55991) [Abstract]. Journal of Clinical Oncology. Abstracts of the 43rd Annual Meeting of the American Society of Clinical Oncology2007;25(18 Suppl):Abstract 5503. HogbergT , SignorelliM , deOliveiraCF , FossatiR , LissoniAA , SorbeB , et al. Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studies. European Journal of Cancer2010;46(13):2422-31. ">Hogberg 2010</a>; <a href="./references#CD010681-bbs2-0010" title="KuoppalaT , MäenpääJ , TomasE , PuistolaU , SalmiT , GrenmanS , et al. Surgically staged high-risk endometrial cancer: randomized study of adjuvant radiotherapy alone vs. sequential chemo-radiotherapy. Gynecologic Oncology2008;110(2):190-5. ">Kuoppala 2008</a>); </p> </li> <li> <p>Study was not a RCT (<a href="./references#CD010681-bbs2-0011" title="MusteaA , KoensgenD , BelauA , SehouliJ , LichteneggerW , SchneidewindL , et al. Adjuvant sequential chemoradiation therapy in high-risk endometrial cancer: results of a prospective, multicenter phase-II study of the NOGGO (North-Eastern German Society of Gynaecological Oncology). Cancer Chemotherapy and Pharmacology2013;72(5):975-83. ">Mustea 2013</a>); </p> </li> <li> <p>Study was conducted in women with uterine sarcomas not endometrial carcinoma (<a href="./references#CD010681-bbs2-0013" title="WolfsonAH , BradyMF , RoceretoT , MannelRS , Lee Y-C, Futoran RJ et al. A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus. Gynecologic Oncology2007;107(2):177-185. ">Wolfson 2007</a>). </p> </li> </ul> </p> </section> </section> <section id="CD010681-sec-0041"> <h3 class="title">Risk of bias in included studies</h3> <p>Included trials were of high quality and we considered them to be at low risk of bias. We have summarised the risk of bias in the included trials in <a href="#CD010681-fig-0001">Figure 1</a>. Also, we have listed details with support for judgement in the 'Risk of Bias' section of the <a href="./references#CD010681-sec-0075" title="">Characteristics of included studies</a> tables. </p> </section> <section id="CD010681-sec-0042"> <h3 class="title" id="CD010681-sec-0042">Effects of interventions</h3> <p>See: <a href="./full#CD010681-tbl-0001"><b>Summary of findings 1</b> Summary of findings</a>; <a href="./full#CD010681-tbl-0002"><b>Summary of findings 2</b> Summary of findings</a> </p> <section id="CD010681-sec-0043"> <h4 class="title">A. Adjuvant chemotherapy versus adjuvant radiotherapy</h4> <p>Two trials provided survival data (<a href="./references#CD010681-bbs2-0001" title="BrunerDW , BarsevickA , TianC , RandallM , MannelR , CohnDE , et al. Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: A Gynecologic Oncology Group study. Quality of Life Research2007;16(1):89-100. RandallME , FiliaciVL , MussH , SpirtosNM , MannelRS , FowlerJ , et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. Journal of Clinical Oncology2006;24(1):36-44. TewariKS , FiliaciVL , SpirtosNM , MannelRS , ThigpenJT , CibullML , et al. Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: a Gynecologic Oncology Group study. Gynecologic Oncology2012;125(1):87-93. ">GOG 122</a>; <a href="./references#CD010681-bbs2-0003" title="MaggiR , LissoniA , SpinaF , MelpignanoM , ZolaP , FavalliG , et al. Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. British Journal of Cancer2006;95(3):266-71. ">Maggi 2006</a>) and assessed 620 women with advanced endometrial cancer (83% stage III, 17% stage IV). We were unable to perform meta‐analysis of severe adverse events due to insufficient data. </p> <section id="CD010681-sec-0044"> <h5 class="title">Overall survival</h5> <p>OS was statistically significantly improved in women with stage III/IV endometrial cancer after receiving adjuvant chemotherapy compared with adjuvant radiotherapy (HR 0.75, 95% CI 0.57 to 0.99, two trials, 620 women; I² = 22%; RE; <a href="./references#CD010681-fig-0005" title="">Analysis 1.1</a>; <a href="#CD010681-fig-0003">Figure 3</a>). This survival benefit was evident in a subgroup analysis, whereby only stage III data were pooled (HR 0.76, 95% CI 0.57 to 1.02, two trials, 514 women; I² = 9%; RE), and for the stage IV data derived from one trial only (HR 0.68, 95% CI 0.44 to 1.04, one trial, 106 women); although the latter was not statistically significant. There was no statistically significant difference between the stage III and stage IV subgroups. </p> <div class="figure" id="CD010681-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Chemotherapy vs radiotherapy, outcome: 1.1 OS (Stage III/IV)." data-id="CD010681-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Chemotherapy vs radiotherapy, outcome: 1.1 OS (Stage III/IV). </p> </div> </div> </div> <p>Data for both trials had been adjusted for stage, therefore we performed a sensitivity analysis with unadjusted data to determine whether the adjustments had impacted the results. The results of OS using unadjusted data were similar using the random‐effects model: HR 0.75, 95% CI 0.60 to 0.94; I² = 0%; RE; <a href="./references#CD010681-fig-0006" title="">Analysis 1.2</a>). Estimated risk ratios (dichotomous data) suggested a similar OS benefit in favour of adjuvant chemotherapy (RR 0.79, 95% CI 0.68 to 0.93; I² = 0%; <a href="./references#CD010681-fig-0007" title="">Analysis 1.3</a>). Separate stage III meta‐analysis of dichotomous data also yielded similar results (RR 0.76, 95% CI 0.62 to 0.93; I² = 0%, <a href="./references#CD010681-fig-0009" title="">Analysis 1.5</a>). </p> <p>In exploratory meta‐analyses (<a href="./references#CD010681-fig-0008" title="">Analysis 1.4</a>) of sub‐stages IIIA (HR 0.61, 95% CI 0.38 to 0.98, two trials, 234 women; I² = 0%); and IIIC (HR 0.76, 95% CI 0.53 to 1.09; two trials, 265 women; I² = 0%) (IIIB sample was too small for analysis), there was no statistically significant difference in effect (test for subgroup differences: Chi² = 0.50, df = 2 (P = 0.48), I² = 0%; <a href="./references#CD010681-fig-0008" title="">Analysis 1.4</a>). </p> </section> <section id="CD010681-sec-0045"> <h5 class="title">Progression‐free survival</h5> <p>PFS was statistically significantly improved in women with stage III/IV endometrial cancer after receiving adjuvant chemotherapy compared with adjuvant radiotherapy (HR 0.74, 95% CI 0.59 to 0.92, two trials, 620 women; I² = 0%; RE; <a href="./references#CD010681-fig-0010" title="">Analysis 1.6</a>; <a href="#CD010681-fig-0004">Figure 4</a>). This survival benefit was evident in subgroup analysis, whereby stage III data were pooled (HR 0.81, 95% CI 0.63 to 1.05, two trials, 514 women; I² = 0%; RE), and for the stage IV data derived from one trial only (HR 0.57, 95% CI 0.38 to 0.86, one trial, 106 women). The magnitude of the effect was smaller for dichotomous data overall (RR 0.89, 95% CI 0.77 to 1.02; I² = 0%; <a href="./references#CD010681-fig-0011" title="">Analysis 1.7</a>), but similar for stage III only (RR 0.84, 95% CI 0.70 to 1.01; I² = 0%, <a href="./references#CD010681-fig-0013" title="">Analysis 1.9</a>). </p> <div class="figure" id="CD010681-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Chemotherapy versus radiotherapy, outcome: 1.6 PFS (Stage III/IV)." data-id="CD010681-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-FIG-04.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Chemotherapy versus radiotherapy, outcome: 1.6 PFS (Stage III/IV). </p> </div> </div> </div> <p>In exploratory meta‐analyses (<a href="./references#CD010681-fig-0012" title="">Analysis 1.8</a>) of sub‐stages IIIA (HR 0.66, 95% CI 0.43 to 1.01, two trials, 234 women; I² = 0%); and IIIC (HR 0.86, 95% CI 0.61 to 1.21, two trials, 265 women; I² = 0%) (IIIB sample was too small for analysis), there was no statistically significant difference in effect (test for subgroup differences: Chi² = 0.92, df = 2 (P = 0.34), I² = 0%; <a href="./references#CD010681-fig-0012" title="">Analysis 1.8</a>). </p> </section> <section id="CD010681-sec-0046"> <h5 class="title">Severe adverse events</h5> <p><a href="./references#CD010681-bbs2-0001" title="BrunerDW , BarsevickA , TianC , RandallM , MannelR , CohnDE , et al. Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: A Gynecologic Oncology Group study. Quality of Life Research2007;16(1):89-100. RandallME , FiliaciVL , MussH , SpirtosNM , MannelRS , FowlerJ , et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. Journal of Clinical Oncology2006;24(1):36-44. TewariKS , FiliaciVL , SpirtosNM , MannelRS , ThigpenJT , CibullML , et al. Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: a Gynecologic Oncology Group study. Gynecologic Oncology2012;125(1):87-93. ">GOG 122</a> reported significantly more haematological and neurological SAEs with adjuvant chemotherapy compared with the adjuvant radiotherapy, as well as significantly more alopecia, and significantly more women discontinued treatment due to toxicity in the chemotherapy arm (<a href="./references#CD010681-fig-0015" title="">Analysis 1.11</a>). There was no statistically significant difference in treatment related deaths (RR 1.67, 95% CI 0.55 to 5.00, two trials, 620 women; <a href="./references#CD010681-fig-0016" title="">Analysis 1.12</a>). </p> <p>Separate SAE data for <a href="./references#CD010681-bbs2-0003" title="MaggiR , LissoniA , SpinaF , MelpignanoM , ZolaP , FavalliG , et al. Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. British Journal of Cancer2006;95(3):266-71. ">Maggi 2006</a> and <a href="./references#CD010681-bbs2-0004" title="SusumuN , SagaeS , UdagawaY , NiwaK , KuramotoH , SatohS , et al. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecologic Oncology2008;108(1):226-33. ">Susumu 2008</a> were not available for stage III participants only. Overall, grade 3/4 neutropenia occurred in 35% of women in the chemotherapy arm of <a href="./references#CD010681-bbs2-0003" title="MaggiR , LissoniA , SpinaF , MelpignanoM , ZolaP , FavalliG , et al. Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. British Journal of Cancer2006;95(3):266-71. ">Maggi 2006</a>. Gastrointestinal toxicity (G3/4) occurred in 11% and 16% of women in the chemotherapy and radiotherapy arms, respectively. <a href="./references#CD010681-bbs2-0004" title="SusumuN , SagaeS , UdagawaY , NiwaK , KuramotoH , SatohS , et al. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecologic Oncology2008;108(1):226-33. ">Susumu 2008</a> reported total G3/G4 toxicities as 9/192 (4.7%) for the chemotherapy arm and 3/193 (1.6%) for the radiotherapy arm. Bowel‐obstruction was the main complication in the radiotherapy group whereas myelosuppression was the main complication in the chemotherapy group. <a href="./references#CD010681-bbs2-0003" title="MaggiR , LissoniA , SpinaF , MelpignanoM , ZolaP , FavalliG , et al. Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. British Journal of Cancer2006;95(3):266-71. ">Maggi 2006</a> and <a href="./references#CD010681-bbs2-0004" title="SusumuN , SagaeS , UdagawaY , NiwaK , KuramotoH , SatohS , et al. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecologic Oncology2008;108(1):226-33. ">Susumu 2008</a> had no treatment‐related deaths. </p> </section> <section id="CD010681-sec-0047"> <h5 class="title">Quality of life (QoL)</h5> <p>At three months post‐treatment, APN scores were significantly worse in the chemotherapy arm compared with radiotherapy (P &lt; 0.001), and FACE scores were significantly worse in the radiotherapy arm compared with chemotherapy (P = 0.004). FS scores were significantly worse in the radiotherapy arm at end of treatment (EOT) (P &lt; 0.001) compared with the chemotherapy arm, There were no significantly differences in FACT‐G scores at EOT, three months or six months from baseline. </p> </section> </section> <section id="CD010681-sec-0048"> <h4 class="title">B. Comparisons between chemotherapy regimens</h4> <p>One trial, including 552 women (88% stage III, 12% stage IV), compared two different chemotherapy regimens (cisplatin/doxorubin/paclitaxel (CDP) versus cisplatin/doxorubicin (CD) treatment) in participants who had received both CRS and adjuvant radiotherapy. There was no statistically significant difference in PFS between treatment arms in this trial (HR 0.90, 95% CI 0.69 to 1.17, one trial, 552 women; <a href="./references#CD010681-fig-0018" title="">Analysis 2.2</a>); however, participants in the CDP arm experienced significantly more severe haematological and neurological adverse events and were possibly more likely to discontinue treatment (<a href="./references#CD010681-fig-0020" title="">Analysis 2.4</a>; not statistically significant). Patient reported FACT‐N scores corresponded with clinician scores and were significantly worse in the triplet regimen group (P &lt; 0.001) at the four week and six month time points. </p> </section> <section id="CD010681-sec-0049"> <h4 class="title">C. Comparison between adjuvant chemotherapy and chemoradiation</h4> <p>We identified one ongoing RCT of this intervention (<a href="./references#CD010681-bbs2-0014" title="Gynecologic Oncology Group. Carboplatin and paclitaxel with or without cisplatin and radiation therapy in treating patients with stage I, stage II, stage III, or stage IVA endometrial cancer. http://www.controlled-trials.com/mrct/trial/587551/endometrial+cancer (accessed 11 November 2013). ">GOG 0258</a>) and will include the results in this review when they are available. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010681-sec-0050" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010681-sec-0050"></div> <section id="CD010681-sec-0051"> <h3 class="title" id="CD010681-sec-0051">Summary of main results</h3> <p>Women with advanced endometrial cancer (FIGO stage III and IV) survived approximately 25% longer if they received chemotherapy after primary surgery, compared with radiotherapy (95% CI 1% to 43%; see <a href="./full#CD010681-tbl-0001">summary of findings Table 1</a>). PFS was 26% longer with adjuvant chemotherapy compared with radiotherapy (95% CI 8% to 41%). In subgroup analyses, the effects on survival in favour of chemotherapy were not different for stage III and IV, or stage IIIA and IIIC (tests for subgroup differences were not significant). </p> <p>The four included trials used three different platinum‐based chemotherapy drug combinations (<a href="./references#CD010681-bbs2-0001" title="BrunerDW , BarsevickA , TianC , RandallM , MannelR , CohnDE , et al. Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: A Gynecologic Oncology Group study. Quality of Life Research2007;16(1):89-100. RandallME , FiliaciVL , MussH , SpirtosNM , MannelRS , FowlerJ , et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. Journal of Clinical Oncology2006;24(1):36-44. TewariKS , FiliaciVL , SpirtosNM , MannelRS , ThigpenJT , CibullML , et al. Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: a Gynecologic Oncology Group study. Gynecologic Oncology2012;125(1):87-93. ">GOG 122</a>: cisplatin/doxorubicin (CD); <a href="./references#CD010681-bbs2-0003" title="MaggiR , LissoniA , SpinaF , MelpignanoM , ZolaP , FavalliG , et al. Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. British Journal of Cancer2006;95(3):266-71. ">Maggi 2006</a> and <a href="./references#CD010681-bbs2-0004" title="SusumuN , SagaeS , UdagawaY , NiwaK , KuramotoH , SatohS , et al. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecologic Oncology2008;108(1):226-33. ">Susumu 2008</a>: cisplatin/doxorubicin/cyclophosphamide (CDC); and <a href="./references#CD010681-bbs2-0002" title="HomesleyHD , FiliaciV , GibbonsSK , LongHJ , CellaD , SpirtosNM , et al. A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study. Gynecologic Oncology2009;112(3):543-52. ">GOG 184</a>: CD plus paclitaxel (CDP) versus CD). Drug doses and median number of cycles differed between the trials, with 50% or more participants receiving 3, 5 and 8 cycles in <a href="./references#CD010681-bbs2-0004" title="SusumuN , SagaeS , UdagawaY , NiwaK , KuramotoH , SatohS , et al. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecologic Oncology2008;108(1):226-33. ">Susumu 2008</a>, <a href="./references#CD010681-bbs2-0003" title="MaggiR , LissoniA , SpinaF , MelpignanoM , ZolaP , FavalliG , et al. Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. British Journal of Cancer2006;95(3):266-71. ">Maggi 2006</a> and <a href="./references#CD010681-bbs2-0001" title="BrunerDW , BarsevickA , TianC , RandallM , MannelR , CohnDE , et al. Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: A Gynecologic Oncology Group study. Quality of Life Research2007;16(1):89-100. RandallME , FiliaciVL , MussH , SpirtosNM , MannelRS , FowlerJ , et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. Journal of Clinical Oncology2006;24(1):36-44. TewariKS , FiliaciVL , SpirtosNM , MannelRS , ThigpenJT , CibullML , et al. Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: a Gynecologic Oncology Group study. Gynecologic Oncology2012;125(1):87-93. ">GOG 122</a>, respectively. <a href="./references#CD010681-bbs2-0004" title="SusumuN , SagaeS , UdagawaY , NiwaK , KuramotoH , SatohS , et al. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecologic Oncology2008;108(1):226-33. ">Susumu 2008</a> reported correspondingly fewer severe adverse events in the chemotherapy arm compared with the other two trials. There was no statistically significant difference in PFS when CDP was compared with CD in <a href="./references#CD010681-bbs2-0002" title="HomesleyHD , FiliaciV , GibbonsSK , LongHJ , CellaD , SpirtosNM , et al. A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study. Gynecologic Oncology2009;112(3):543-52. ">GOG 184</a>, the only included trial that compared two adjuvant chemotherapy regimens. We are awaiting mature OS results from this trial. </p> </section> <section id="CD010681-sec-0052"> <h3 class="title" id="CD010681-sec-0052">Overall completeness and applicability of evidence</h3> <p>We consider this evidence to be applicable to most women with stage III and IV disease, when adjuvant chemotherapy is started within eight weeks of primary surgery. However, the majority of women taking part in these trials had a high performance status, which does not reflect the performance status of all women with advanced endometrial cancer, particularly the elderly, who are more susceptible to toxicity from chemotherapeutic agents. We were unable to perform subgroup analyses according to age or other risk factors, due to insufficient data. Therefore, it is likely that the extent of the survival benefit of adjuvant chemotherapy compared with adjuvant radiotherapy will vary depending on these additional risk factors, and that individualised treatment of these women will be needed. In addition, women with stage IIIB were poorly represented in these data. It is possible that women with stage IIIB (vaginal spread) would receive more benefit from adjuvant radiotherapy or chemoradiation. Further research is needed to determine whether and in whom the addition of radiotherapy will be beneficial. </p> <p>Further research is needed to determine which adjuvant chemotherapy regimen gives the best results. The chemotherapy arm in <a href="./references#CD010681-bbs2-0004" title="SusumuN , SagaeS , UdagawaY , NiwaK , KuramotoH , SatohS , et al. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecologic Oncology2008;108(1):226-33. ">Susumu 2008</a> experienced less G3/G4 toxicity compared with the other trials in this review which may be attributable to fewer cycles (median = 3) or the lower doxorubicin dose administered (40 mg/m<sup>2</sup>). We await the final results of <a href="./references#CD010681-bbs2-0002" title="HomesleyHD , FiliaciV , GibbonsSK , LongHJ , CellaD , SpirtosNM , et al. A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study. Gynecologic Oncology2009;112(3):543-52. ">GOG 184</a>, as well as the results of a large trial of chemoradiation and adjuvant chemotherapy versus adjuvant chemotherapy only in advanced disease (<a href="./references#CD010681-bbs2-0014" title="Gynecologic Oncology Group. Carboplatin and paclitaxel with or without cisplatin and radiation therapy in treating patients with stage I, stage II, stage III, or stage IVA endometrial cancer. http://www.controlled-trials.com/mrct/trial/587551/endometrial+cancer (accessed 11 November 2013). ">GOG 0258</a>). In addition, the results of <a href="./references#CD010681-bbs2-0015" title="PORTEC-3 collaborators. Chemotherapy and radiation therapy compared with radiation therapy alone in treating patients with high-risk stage I, stage II, or stage III endometrial cancer. http://www.controlled-trials.com/mrct/trial/386235/PORTEC-32012. ">PORTEC‐3</a>, a trial of adjuvant chemoradiation versus radiotherapy that includes women with stage III disease will contribute to the growing body of evidence on the management of advanced endometrial cancer. </p> </section> <section id="CD010681-sec-0053"> <h3 class="title" id="CD010681-sec-0053">Quality of the evidence</h3> <p>The overall risk of bias of included trials was low to moderate. Previously, <a href="./references#CD010681-bbs2-0001" title="BrunerDW , BarsevickA , TianC , RandallM , MannelR , CohnDE , et al. Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: A Gynecologic Oncology Group study. Quality of Life Research2007;16(1):89-100. RandallME , FiliaciVL , MussH , SpirtosNM , MannelRS , FowlerJ , et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. Journal of Clinical Oncology2006;24(1):36-44. TewariKS , FiliaciVL , SpirtosNM , MannelRS , ThigpenJT , CibullML , et al. Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: a Gynecologic Oncology Group study. Gynecologic Oncology2012;125(1):87-93. ">GOG 122</a> has been criticised for reporting adjusted data (<a href="./references#CD010681-bbs2-0032" title="JohnsonN , BryantA , MilesT , HogbergT , CornesP . Adjuvant chemotherapy for endometrial cancer after hysterectomy. Cochrane Database of Systematic Reviews2011, Issue 10. Art. No: CD003175. [DOI: 10.1002/14651858.CD003175.pub2]">Johnson 2011</a>), therefore we performed sensitivity analyses using adjusted and unadjusted data from <a href="./references#CD010681-bbs2-0001" title="BrunerDW , BarsevickA , TianC , RandallM , MannelR , CohnDE , et al. Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: A Gynecologic Oncology Group study. Quality of Life Research2007;16(1):89-100. RandallME , FiliaciVL , MussH , SpirtosNM , MannelRS , FowlerJ , et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. Journal of Clinical Oncology2006;24(1):36-44. TewariKS , FiliaciVL , SpirtosNM , MannelRS , ThigpenJT , CibullML , et al. Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: a Gynecologic Oncology Group study. Gynecologic Oncology2012;125(1):87-93. ">GOG 122</a> and <a href="./references#CD010681-bbs2-0003" title="MaggiR , LissoniA , SpinaF , MelpignanoM , ZolaP , FavalliG , et al. Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. British Journal of Cancer2006;95(3):266-71. ">Maggi 2006</a> for overall survival. For the former we used the estimate in <a href="./references#CD010681-bbs2-0032" title="JohnsonN , BryantA , MilesT , HogbergT , CornesP . Adjuvant chemotherapy for endometrial cancer after hysterectomy. Cochrane Database of Systematic Reviews2011, Issue 10. Art. No: CD003175. [DOI: 10.1002/14651858.CD003175.pub2]">Johnson 2011</a>; for the latter we obtained these from the principal investigators. We used the random‐effects model for survival meta‐analyses even though statistical heterogeneity was minimal. The unadjusted data for OS gave the same point estimate as adjusted data, with a narrower CI and no statistical heterogeneity. We therefore consider the evidence relating to survival for the comparison adjuvant chemotherapy versus radiotherapy to be consistent and reasonably precise, with minimal heterogeneity. Since the survival effect using dichotomous data was greater for OS than for PFS, it has been suggested that the overall survival benefit in favour of chemotherapy may have been impacted by subsequent salvage radiotherapy. Therefore we downgraded the evidence to moderate quality. We also consider the evidence for the comparison of the CDP versus CD regimens to be of moderate quality, pending assessment of the final survival results. </p> </section> <section id="CD010681-sec-0054"> <h3 class="title" id="CD010681-sec-0054">Potential biases in the review process</h3> <p>We obtained and included unpublished data from <a href="./references#CD010681-bbs2-0003" title="MaggiR , LissoniA , SpinaF , MelpignanoM , ZolaP , FavalliG , et al. Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. British Journal of Cancer2006;95(3):266-71. ">Maggi 2006</a>, which included a significant proportion of stage III patients (64%). We also requested stage III data from the investigators of the <a href="./references#CD010681-bbs2-0004" title="SusumuN , SagaeS , UdagawaY , NiwaK , KuramotoH , SatohS , et al. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecologic Oncology2008;108(1):226-33. ">Susumu 2008</a> trial, comprising 25% of the sample size of this trial. The latter trial included women with stages 1C to IIIC but did not stratify randomisation according to stage of disease; they reported no significant differences in survival between women in the adjuvant chemotherapy and radiotherapy groups overall. However, in subgroup analyses of 120 women with high‐intermediate risk disease, chemotherapy was associated with a significantly improved survival (OS and PFS) compared with the radiotherapy. In further ad‐hoc analyses of 75 of these women considered to be 'high risk' (stage IIIB/C and IIIA with additional risk factors), there was no significant difference in survival between the trial arms. Due to concerns about bias, we decided to await separate stage III data (97 women) as the paper lacked sufficient detail about this subgroup (e.g. the number of high risk women evaluable in each group). We intend to include these requested data in the review when they become available; however, based on the published data from this trial and the small numbers involved, we do not expect that these data will significantly alter the review findings. </p> </section> <section id="CD010681-sec-0055"> <h3 class="title" id="CD010681-sec-0055">Agreements and disagreements with other studies or reviews</h3> <p><a href="./references#CD010681-bbs2-0032" title="JohnsonN , BryantA , MilesT , HogbergT , CornesP . Adjuvant chemotherapy for endometrial cancer after hysterectomy. Cochrane Database of Systematic Reviews2011, Issue 10. Art. No: CD003175. [DOI: 10.1002/14651858.CD003175.pub2]">Johnson 2011</a> concluded that adjuvant chemotherapy could be used as an alternative, or addition to, adjuvant radiotherapy in women with endometrial cancer. The review combined data from studies of adjuvant chemotherapy or chemoradiation compared to radiotherapy for any stage of endometrial cancer or uterine sarcoma. Thus, there was substantial clinical heterogeneity in the interventions and the participants included in <a href="./references#CD010681-bbs2-0032" title="JohnsonN , BryantA , MilesT , HogbergT , CornesP . Adjuvant chemotherapy for endometrial cancer after hysterectomy. Cochrane Database of Systematic Reviews2011, Issue 10. Art. No: CD003175. [DOI: 10.1002/14651858.CD003175.pub2]">Johnson 2011</a>. <a href="./references#CD010681-bbs2-0032" title="JohnsonN , BryantA , MilesT , HogbergT , CornesP . Adjuvant chemotherapy for endometrial cancer after hysterectomy. Cochrane Database of Systematic Reviews2011, Issue 10. Art. No: CD003175. [DOI: 10.1002/14651858.CD003175.pub2]">Johnson 2011</a> also included trials conducted mainly in women with endometrial cancer stages III and IV (<a href="./references#CD010681-bbs2-0001" title="BrunerDW , BarsevickA , TianC , RandallM , MannelR , CohnDE , et al. Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: A Gynecologic Oncology Group study. Quality of Life Research2007;16(1):89-100. RandallME , FiliaciVL , MussH , SpirtosNM , MannelRS , FowlerJ , et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. Journal of Clinical Oncology2006;24(1):36-44. TewariKS , FiliaciVL , SpirtosNM , MannelRS , ThigpenJT , CibullML , et al. Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: a Gynecologic Oncology Group study. Gynecologic Oncology2012;125(1):87-93. ">GOG 122</a>; <a href="./references#CD010681-bbs2-0003" title="MaggiR , LissoniA , SpinaF , MelpignanoM , ZolaP , FavalliG , et al. Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. British Journal of Cancer2006;95(3):266-71. ">Maggi 2006</a>), comprising a significant proportion of these pooled data (&gt; 50%) and having a significant impact on their overall results. If these studies are excluded from their meta‐analyses of chemotherapy versus radiotherapy, the pooled results for survival with earlier stages of endometrial cancer would not be statistically significantly different. Following some controversy over the use of adjusted or unadjusted results in <a href="./references#CD010681-bbs2-0001" title="BrunerDW , BarsevickA , TianC , RandallM , MannelR , CohnDE , et al. Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: A Gynecologic Oncology Group study. Quality of Life Research2007;16(1):89-100. RandallME , FiliaciVL , MussH , SpirtosNM , MannelRS , FowlerJ , et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. Journal of Clinical Oncology2006;24(1):36-44. TewariKS , FiliaciVL , SpirtosNM , MannelRS , ThigpenJT , CibullML , et al. Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: a Gynecologic Oncology Group study. Gynecologic Oncology2012;125(1):87-93. ">GOG 122</a>, we considered it important to try to clarify the role of adjuvant chemotherapy for advanced endometrial cancer, by obtaining unpublished data from other similar trials. Our review of adjuvant chemotherapy in advanced disease, which incorporates unpublished data from <a href="./references#CD010681-bbs2-0003" title="MaggiR , LissoniA , SpinaF , MelpignanoM , ZolaP , FavalliG , et al. Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. British Journal of Cancer2006;95(3):266-71. ">Maggi 2006</a>, suggests a survival advantage of adjuvant chemotherapy over radiotherapy in stage III/IV disease with minimal heterogeneity in meta‐analyses using random‐effects models. </p> <p>What remains to be determined is whether and in whom the addition of radiotherapy in advanced disease may be helpful. An ongoing trial commenced in 2009, of adjuvant chemoradiation and chemotherapy versus adjuvant chemotherapy alone in high risk endometrial cancer (defined in this trial as FIGO stage III/IV disease, and stage I/II clear cell and papillary serous), is expected to be completed in 2016 (<a href="./references#CD010681-bbs2-0014" title="Gynecologic Oncology Group. Carboplatin and paclitaxel with or without cisplatin and radiation therapy in treating patients with stage I, stage II, stage III, or stage IVA endometrial cancer. http://www.controlled-trials.com/mrct/trial/587551/endometrial+cancer (accessed 11 November 2013). ">GOG 0258</a>). In this multicentre, parallel RCT, women are randomised to receive, either a 'sandwich' treatment of cisplatin (day 1 and 29), followed by radiotherapy and four cycles of carboplatin/paclitaxel, or six cycles of carboplatin/paclitaxel from day one. There have been no studies to date evaluating the 'sandwich' technique in advanced endometrial cancer, which may offer additional benefits. </p> <p>A review of (non‐adjuvant) chemotherapy for advanced, recurrent or metastatic endometrial carcinoma found evidence from eight RCTs that 'more chemotherapy' was associated with a longer overall survival than 'less chemotherapy' (<a href="./references#CD010681-bbs2-0038" title="ValeCL , TierneyJ , BullSJ , SymondsPR . Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma. Cochrane Database of Systematic Reviews2012, Issue 8. Art. No: CD003915. [DOI: 10.1002/14651858.CD003915.pub4]">Vale 2012</a>). When it comes to adjuvant chemotherapy, this may not be the case. Mature data from <a href="./references#CD010681-bbs2-0002" title="HomesleyHD , FiliaciV , GibbonsSK , LongHJ , CellaD , SpirtosNM , et al. A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study. Gynecologic Oncology2009;112(3):543-52. ">GOG 184</a> are awaited with interest. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010681-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/urn:x-wiley:14651858:media:CD010681:CD010681-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included trial." data-id="CD010681-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-FIG-01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_t/tCD010681-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/full#CD010681-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-FIG-01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010681-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/urn:x-wiley:14651858:media:CD010681:CD010681-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD010681-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-FIG-02.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_t/tCD010681-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/full#CD010681-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-FIG-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010681-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/urn:x-wiley:14651858:media:CD010681:CD010681-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Chemotherapy vs radiotherapy, outcome: 1.1 OS (Stage III/IV)." data-id="CD010681-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_t/tCD010681-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Chemotherapy vs radiotherapy, outcome: 1.1 OS (Stage III/IV). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/full#CD010681-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010681-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/urn:x-wiley:14651858:media:CD010681:CD010681-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Chemotherapy versus radiotherapy, outcome: 1.6 PFS (Stage III/IV)." data-id="CD010681-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-FIG-04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_t/tCD010681-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Chemotherapy versus radiotherapy, outcome: 1.6 PFS (Stage III/IV). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/full#CD010681-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-FIG-04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010681-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/urn:x-wiley:14651858:media:CD010681:CD010681-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Chemotherapy vs radiotherapy, Outcome 1: OS (Stage III/IV)" data-id="CD010681-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_t/tCD010681-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Chemotherapy vs radiotherapy, Outcome 1: OS (Stage III/IV)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/references#CD010681-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010681-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/urn:x-wiley:14651858:media:CD010681:CD010681-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Chemotherapy vs radiotherapy, Outcome 2: OS (stage III/IV) (unadjusted data)" data-id="CD010681-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_t/tCD010681-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Chemotherapy vs radiotherapy, Outcome 2: OS (stage III/IV) (unadjusted data) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/references#CD010681-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010681-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/urn:x-wiley:14651858:media:CD010681:CD010681-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Chemotherapy vs radiotherapy, Outcome 3: OS (stage III/IV dichotomous)" data-id="CD010681-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_t/tCD010681-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Chemotherapy vs radiotherapy, Outcome 3: OS (stage III/IV dichotomous)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/references#CD010681-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010681-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/urn:x-wiley:14651858:media:CD010681:CD010681-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Chemotherapy vs radiotherapy, Outcome 4: OS (Stage III only)" data-id="CD010681-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_t/tCD010681-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Chemotherapy vs radiotherapy, Outcome 4: OS (Stage III only)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/references#CD010681-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010681-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/urn:x-wiley:14651858:media:CD010681:CD010681-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Chemotherapy vs radiotherapy, Outcome 5: OS (Stage III dichotomous)" data-id="CD010681-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_t/tCD010681-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Chemotherapy vs radiotherapy, Outcome 5: OS (Stage III dichotomous)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/references#CD010681-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010681-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/urn:x-wiley:14651858:media:CD010681:CD010681-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Chemotherapy vs radiotherapy, Outcome 6: PFS (Stage III/IV)" data-id="CD010681-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_t/tCD010681-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Chemotherapy vs radiotherapy, Outcome 6: PFS (Stage III/IV)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/references#CD010681-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010681-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/urn:x-wiley:14651858:media:CD010681:CD010681-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Chemotherapy vs radiotherapy, Outcome 7: PFS (stage III/IV dichotomous)" data-id="CD010681-fig-0011" src="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_t/tCD010681-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: Chemotherapy vs radiotherapy, Outcome 7: PFS (stage III/IV dichotomous)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/references#CD010681-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010681-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/urn:x-wiley:14651858:media:CD010681:CD010681-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Chemotherapy vs radiotherapy, Outcome 8: PFS (Stage III only)" data-id="CD010681-fig-0012" src="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_t/tCD010681-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: Chemotherapy vs radiotherapy, Outcome 8: PFS (Stage III only)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/references#CD010681-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010681-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/urn:x-wiley:14651858:media:CD010681:CD010681-CMP-001.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Chemotherapy vs radiotherapy, Outcome 9: PFS (Stage III dichotomous)" data-id="CD010681-fig-0013" src="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-CMP-001.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_t/tCD010681-CMP-001.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: Chemotherapy vs radiotherapy, Outcome 9: PFS (Stage III dichotomous)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/references#CD010681-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-CMP-001.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010681-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/urn:x-wiley:14651858:media:CD010681:CD010681-CMP-001.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Chemotherapy vs radiotherapy, Outcome 10: Severe adverse events (G3/4)" data-id="CD010681-fig-0014" src="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-CMP-001.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_t/tCD010681-CMP-001.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1: Chemotherapy vs radiotherapy, Outcome 10: Severe adverse events (G3/4)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/references#CD010681-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-CMP-001.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010681-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/urn:x-wiley:14651858:media:CD010681:CD010681-CMP-001.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Chemotherapy vs radiotherapy, Outcome 11: Treatment discontinuation due to toxicity" data-id="CD010681-fig-0015" src="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-CMP-001.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_t/tCD010681-CMP-001.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1: Chemotherapy vs radiotherapy, Outcome 11: Treatment discontinuation due to toxicity </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/references#CD010681-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-CMP-001.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010681-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/urn:x-wiley:14651858:media:CD010681:CD010681-CMP-001.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Chemotherapy vs radiotherapy, Outcome 12: Treatment‐related deaths" data-id="CD010681-fig-0016" src="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-CMP-001.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_t/tCD010681-CMP-001.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1: Chemotherapy vs radiotherapy, Outcome 12: Treatment‐related deaths</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/references#CD010681-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-CMP-001.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010681-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/urn:x-wiley:14651858:media:CD010681:CD010681-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: CDP vs CD, Outcome 1: OS (stage III/IV)" data-id="CD010681-fig-0017" src="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_t/tCD010681-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: CDP vs CD, Outcome 1: OS (stage III/IV)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/references#CD010681-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010681-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/urn:x-wiley:14651858:media:CD010681:CD010681-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: CDP vs CD, Outcome 2: PFS (stage III/IV)" data-id="CD010681-fig-0018" src="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_t/tCD010681-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: CDP vs CD, Outcome 2: PFS (stage III/IV)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/references#CD010681-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010681-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/urn:x-wiley:14651858:media:CD010681:CD010681-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: CDP vs CD, Outcome 3: Severe adverse events (G3/4)" data-id="CD010681-fig-0019" src="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_t/tCD010681-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: CDP vs CD, Outcome 3: Severe adverse events (G3/4)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/references#CD010681-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010681-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/urn:x-wiley:14651858:media:CD010681:CD010681-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: CDP vs CD, Outcome 4: Treatment discontinuation" data-id="CD010681-fig-0020" src="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_t/tCD010681-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: CDP vs CD, Outcome 4: Treatment discontinuation</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/references#CD010681-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/media/CDSR/CD010681/image_n/nCD010681-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010681-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Adjuvant chemotherapy (CT) versus adjuvant radiotherapy (RT) for women with stage III and IV endometrial cancer</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population: women with stage III or IV endometrial cancer after primary cytoreductive surgery</b> </p> <p><b>Settings: hospital</b> </p> <p><b>Intervention: CT</b> </p> <p><b>Comparison: RT</b> </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No of participants<br/>(trials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>RT</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>CT</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>5‐ year OS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Stage III</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>HR 0.75</b> (0.57 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>620 women<br/>(2) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/><b>moderate</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="7" valign="top"> <p>For OS, a consistent effect was demonstrated across trials and subgroups (IIIA, IIIC and IV). Dichotomous OS data gave similar results (two trials, RR 0.79, 95% CI 0.68 to 0.93). </p> <p>For PFS, a consistent effect was demonstrated across trials and subgroups (IIIA, IIIC and IV) but the dichotomous data suggests a smaller effect size (two trials, RR 0.89, 95% CI 0.77 to 1.02). We downgraded the quality of evidence due to imprecision (wide CIs) and the possibility that salvage radiotherapy may have contributed to a greater effect size for OS. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>60 women alive per 100 diagnosed</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>75 women alive per 100 diagnosed</b> (61 to 86) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Stage IV</b> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>30 women alive per 100 diagnosed</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>38 women alive per 100 diagnosed</b> (30 to 50) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>5‐year PFS</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Not estimated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.74</b> (0.59 to 0.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>620 women<br/>(2) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>5‐year OS (stage III)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Not estimated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.76</b> </p> <p>(0.57 to 1.02)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>514 women</p> <p>(2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>5‐year PFS (stage III)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Not estimated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.81</b> (0.63 to 1.05) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>514 women</p> <p>(2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The <b>assumed risk</b> is based on SEER survival data (<a href="./references#CD010681-bbs2-0037" title="KosaryCL . Chapter 15: Cancer of the corpus uteri. In: Gloeckler RiesLA , YoungJL , KeelGE , EisnerMP , LinYD , Horner M-J, editors(s). Cancer survival among adults: US SEER program, 1988-2001. Patient and Tumor Characteristics. Bethesda, MD: National Cancer Institute, 2007:123-132.">SEER 2007</a>). Use of these data assumes that the adjuvant treatment of choice from 1988 to 2001 was radiotherapy. Assumed risk varies depending on other risk factors, such as age and histology. </p> <p>The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI</b> : Confidence interval; <b>HR</b> : Hazard ratio; <b>OS</b> : Overall survival; <b>PFS</b> : Progression‐free survival; <b>CT</b> : chemotherapy; <b>RT</b>: radiotherapy. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/full#CD010681-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD010681-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Summary of findings</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Adjuvant cisplatin/doxorubicin/paclitaxel (CDP) compared with cisplatin/doxorubicin (CD) for women with advanced (stage III/IV) endometrial cancer</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Patient or population:</b> women with advanced (stage III/IV) endometrial cancer after surgery and radiotherapy </p> <p><b>Settings:</b> hospital </p> <p><b>Intervention: CDP</b> </p> <p><b>Comparison: CD</b> </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>No of participants<br/>(trials)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PFS (stage III/IV)</b> </p> <p>Median follow‐up 46/47 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>HR 0.90</b> (0.69 to 1.17) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>552<br/>(1) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We considered this evidence high quality but downgraded it to moderate, as mature OS data has not yet been published, therefore we cannot exclude other differences in survival risks/benefits. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>CI</b> : Confidence interval; <b>HR</b> : Hazard ratio; <b>PFS</b> : Progression‐free survival; <b>CDP</b> : cisplatin/doxorubicin/paclitaxel; <b>CD</b>: cisplatin/doxorubicin. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Summary of findings</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/full#CD010681-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010681-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Chemotherapy vs radiotherapy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 OS (Stage III/IV) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 Stage III</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>514</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.57, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.2 Stage IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.44, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.3 Stage III/IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>620</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.57, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 OS (stage III/IV) (unadjusted data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.60, 0.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 OS (stage III/IV dichotomous) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>620</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.68, 0.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 OS (Stage III only) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 Stage IIIA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>234</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.38, 0.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.2 Stage IIIC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>265</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.53, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 OS (Stage III dichotomous) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>514</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.62, 0.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 PFS (Stage III/IV) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.1 Stage III</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>514</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.63, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.2 Stage IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.38, 0.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.3 Stage III/IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>620</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.59, 0.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 PFS (stage III/IV dichotomous) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>620</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.77, 1.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 PFS (Stage III only) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.1 Stage IIIA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>234</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.43, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.2 Stage IIIC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>265</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.61, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 PFS (Stage III dichotomous) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>514</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.70, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.10 Severe adverse events (G3/4) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.1 Leukopenia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.2 Neutropenia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.3 Thrombocytopenia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.4 Gastrointestinal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.5 Neurological</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.6 Infection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.7 Skin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.8 Genitourinary</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.9 Alopecia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.11 Treatment discontinuation due to toxicity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.12 Treatment‐related deaths <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>620</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.67 [0.55, 5.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Chemotherapy vs radiotherapy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/references#CD010681-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010681-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">CDP vs CD</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 OS (stage III/IV) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>552</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 PFS (stage III/IV) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Severe adverse events (G3/4) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.1 Leukopenia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.2 Neutropenia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.3 Anaemia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.4 Thrombocytopenia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.5 Gastrointestinal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.6 Neurological</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.7 Infection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.8 Skin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.9 Genitourinary</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.10 Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Treatment discontinuation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">CDP vs CD</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010681.pub2/references#CD010681-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010681.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD010681-note-0009">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010681-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD010681-note-0006">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ms#CD010681-note-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD010681-note-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD010681-note-0005">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010681\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010681\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010681\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010681\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010681\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010681\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010681\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010681\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010681\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010681\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010681\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010681\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010681\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010681\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010681\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010681\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010681\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010681\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Nio3SV1W&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010681.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010681.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010681.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010681.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010681.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740729242987"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010681.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740729242991"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010681.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ed81edf6af55b',t:'MTc0MDcyOTI0My4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 